Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# ELAROS 24/7 Limited

Your Partner in Health Management

## Sitemaps

- [XML Sitemap](https://www.elaros.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [MammoScreen holds its first in person consortium meeting](https://www.elaros.com/mammoscreen-holds-its-first-in-person-consortium-meeting/) - MammoScreen holds its first in person consortium meeting On the 17th and 18th of May, ELAROS had the exciting opportunity to attend the first MammoScreen Consortium Meeting at London Southbank University. The MammoScreen project is a €6M project involving partners from Italy, Spain, Portugal and the UK – Led by Umbria Bioengineering Technologies SRL (UBT).
- [Davide Righi joins ELAROS Summer Placement Programme](https://www.elaros.com/davide-righi-joins-elaros-summer-placement-programme/) - Davide Righi joins ELAROS the annual Summer Placement Programme ELAROS selected Davide Righi to join the company’s 2024 summer placement programme. Davide has just finished his first year studying Bioengineering (BEng) at Loughborough University. He has been drawn to bioengineering both due to his personal interests and the multidisciplinary nature of the degree whilst learning
- [ELAROS appoints Graduate Research and Development Associate](https://www.elaros.com/elaros-appoints-graduate-research-and-development-associate-july-2021/) - ELAROS appoints Graduate Research and Development Associate ELAROS is delighted to announce the appointment of Oscar Petherick, to the post of Graduate Research and Development Associate. His role is mainly focused on supporting the roll-out of the C19-YRS, including its development, the support of users and generation and conversion of interest in the app. He
- [ELAROS partners in £3.4M NIHR study into Long COVID Treatment Pathways](https://www.elaros.com/elaros-partners-in-3-4m-nihr-study-into-long-covid-treatment-pathways/) - ELAROS partners in £3.4M NIHR study into Long COVID Treatment Pathways ELAROS is proud to announce its involvement in the LOCOMOTION (LOng COvid Multidisciplinary consortium: Optimising Treatments and servIces acrOss the Nhs) study, a £3.4 million project led by The University of Leeds which is funded by the National Institute for Health Research (NIHR). The
- [NROL wins national collaboration award at Advancing Healthcare Awards 2026](https://www.elaros.com/nrol-wins-national-collaboration-award-at-advancing-healthcare-awards-2026/) - East Lancashire NHS Trust & Lancaster University win national award at the Advancing Healthcare Awards 2026 for the development of the NROL Programme. We are thrilled to share that our clinical academic partners at East Lancashire NHS Trust and Lancaster University have won a national award at the Advancing Healthcare Awards (AHA) 2026 for the
- [Northern Care Alliance NHS Group report the succeses of the digital C19-YRS platform](https://www.elaros.com/northern-care-alliance-nhs-group-report-the-succeses-of-the-digital-c19-yrs-platform/) - Northern Care Alliance NHS Group report the succeses of the digital C19-YRS platform The Northern Care Alliance NHS group (NCA) has published an article detailing some of their experiences of using the Covid-19 Yorkshire Rehabilitation Scale (C19-YRS). All of the quotes in this article are taken from the original NCA press release which can be
- [ELAROS Participates in the 4th NWC Connected Health Ecosystem Event](https://www.elaros.com/elaros-participates-in-the-4th-nwc-connected-health-ecosystem-event/) - ELAROS Participates in the 4th NWC Connected Health Ecosystem Event ELAROS 24/7 Ltd, a leading provider of clinical decision tools for the triage, diagnosis and management of Lower Urinary Tract Symptoms, has participated in the 4th NWC Connected Health Ecosystem event. The event took place on the 23rd April 2013 at the Langtree Park Stadium in
- [NROL Service Successfully commissioned in Lancashire & South Cumbria ICB](https://www.elaros.com/nrol-service-successfully-commissioned-in-lancashire-south-cumbria-icb/) - NROL Service Successfully commissioned in Lancashire & South Cumbria ICB We are extremely excited and proud to announce ELAROS has been successfully commissioned by Lancashire & South Cumbria ICB to deliver the NeuroRehabilitation OnLine service through our autonom-e platform.Thanks to our successful SBRI Healthcare project which closes in July 2026, led by East Lancashire NHS
- [A milestone for the NHS Neuro Rehabilitation OnLine (NROL) service](https://www.elaros.com/a-milestone-for-the-nhs-neuro-rehabilitation-online-nrol-service/) - A milestone for the NHS Neuro Rehabilitation OnLine (NROL) service A milestone for the NHS NeuroRehabilitation OnLine (NROL) service!We’re incredibly proud to be the technology partner driving the digital NROL service at East Lancashire Hospitals NHS Trust through our autonom-e platform.It’s great to see the continued momentum behind NROL, strengthened by the recent BMJ Open
- [Dr. Clare Williamson Joins ELAROS as Programme Manager](https://www.elaros.com/dr-clare-williamson-joins-elaros-as-programme-manager/) - Dr. Clare Williamson Joins ELAROS as Programme Manager ELAROS is pleased to announce that Dr. Clare Williamson has joined ELAROS as Programme Manager with an initial focus on delivering Elaros’ recently awarded Innovate UK Project. Graduating from King’s College, London, with a BSc (Hons) in Pharmacology & Toxicology, she moved to Sheffield in 1999 where
- [ELAROS appoints Director of Research and Development](https://www.elaros.com/elaros-appoints-director-of-research-and-development/) - ELAROS appoints Director of Research and Development The ELAROS Board is pleased to announce that it has promoted Román Rocha Lawrence to the newly created position of Director of Research & Development. Since starting with ELAROS two years ago, Román has been a driving force for ELAROS across a broad range of the work the
- [ELAROS attends National Long Covid conference](https://www.elaros.com/elaros-attends-national-long-covid-conference/) - ELAROS attends second NHS England National Long COVID Conference On Thursday ELAROS colleagues Román Rocha Lawrence and Henry Robinson attended the second NHS England Long COVID Conference in Edinburgh.The conference featured a line-up of inspirational talks by clinical leads, researchers, allied healthcare professionals and thought leaders in the field, closed by Professor Manoj Sivan announcing
- [NeuroRehabilitation OnLine Service wins NHS Excellence award for Patient Involvement & Choice](https://www.elaros.com/neurorehabilitation-online-service-wins-nhs-excellence-award-for-patient-involvement-choice/) - NeuroRehabilitation OnLine Service wins NHS Excellence award for Patient Involvement & Choice A huge congratulations to our superstar NeuroRehabilitation OnLine team at East Lancashire Hospitals NHS Trust and the wider Lancashire & South Cumbria region for being named Regional Champion for Patient Involvement & Choice at the NHS Excellence Awards. We’ve had the pleasure of
- [ELAROS and Leeds NHS Trust Shortlisted as finalists for National AHSN Network Innovate Awards](https://www.elaros.com/elaros-and-leeds-nhs-trust-shortlisted-as-finalists-for-national-ahsn-network-innovate-awards/) - ELAROS and Leeds NHS Trust Shortlisted as finalists for National AHSN Network Innovate Awards ELAROS is proud to announce that we along with our joint applicant partners – Leeds Teaching Hospitals NHS Foundation Trust and the University of Leeds – have been chosen as the finalists in the ‘Outstanding Collaboration with Industry’ award category. “The
- [Impact of Long COVID quantified by the European Journal of Health Economics](https://www.elaros.com/impact-of-long-covid-quantified-by-the-european-journal-of-health-economics/) - Impact of Long COVID quantified by the European Journal of Health Economics Published on the 26th of December 2023 in the European Journal of Health Economics, doi:10.1007/s10198-023-01653-z‘Impact of Long COVID on productivity and informal caregiving’The abstract of the article and summary points can be read here, but for the full article, please follow any of
- [ELAROS 24/7 Secures Funding From the NENC AHSN](https://www.elaros.com/elaros-24-7-secures-funding-from-the-ahsn/) - ELAROS 24/7 Secures Funding From the NENC AHSN ELAROS 24/7, an innovative new service that improves the initial assessment, diagnosis and triaging of patients with lower urinary tract symptoms (LUTS), has secured £96,000 of funding from the Academic Health Health Science Network for the North East and North Cumbria (AHSN NENC). Of 139 applications submitted to
- [Nathan Wells completes ELAROS' Summer Placement Programme](https://www.elaros.com/nathan-wells-joins-elaros-summer-placement-programme/) - Nathan Wells completes ELAROS' Summer 2023 Placement Programme Nathan has recently completed the company’s summer placement program and has since been invited to work as an intern, after completing a Master’s degree in Bioengineering at the University of Sheffield. During Nathan’s final year at university, he specialised in the bacterial production of biodegradable plastics while
- [Connecting with the Next Generation of Bioengineers at The University of Sheffield](https://www.elaros.com/connecting-with-the-next-generation-of-bioengineers-at-the-university-of-sheffield-2/) - Connecting with the Next Generation of Bioengineers at The University of Sheffield Last week, ELAROS 24/7 Limited had the pleasure of visiting Bioengineering (Interdisciplinary Engineering) University of Sheffield to speak with students as part of their Research Seminars module, organised by Professor Chris Holland.It was fantastic to return as University of Sheffield Bioengineering alumni and
- [ELAROS Joins Global Health Project as Commercial Partner Exploring a New Frontier In Health](https://www.elaros.com/elaros-joins-global-health-project-as-commercial-partner-exploring-a-new-frontier-in-health/) - ELAROS Joins Global Health Project as Commercial Partner Exploring a New Frontier In Health ELAROS has been working with colleagues at London South Bank University for three years on very exciting applications of a technology (currently operating outside of the health/care sectors) that we believe will have a transformational impact upon; healthcare, care, self-management and
- [ELAROS announces December 2025 Webinar Series](https://www.elaros.com/elaros-announces-december-2025-webinar-series/) - ELAROS announces December 2025 Webinar series 09 December, 10 December, 11 December 2025 The team are excited to share a series of webinars in December 2025 to announce a range of new innovations to support the Long COVID and ME/CFS patient, clinical, and academic community.For more information about piloting or using these apps for personal use
- [ME Association announces largest charity funded study on ME/CFS and LC with Imperial College and ELAROS](https://www.elaros.com/me-association-announces-largest-charity-funded-study-on-me-cfs-and-lc-with-imperial-college-and-elaros/) - Major new ME/CFS & Long Covid study launches with Imperial College and the ME Association ELAROS is proud to announce the news of our latest investment into ground-breaking research to help world-leading scientists uncover shared pathways between ME/CFS and Long Covid. The ME Association is investing £1.1m into the Rosetta Stone study – the largest
- [ELAROS Signs New Partnership Deal with The University Of Huddersfield Funded by Grow Medtech](https://www.elaros.com/elaros-signs-new-partnership-deal-with-the-university-of-huddersfield-funded-by-grow-medtech/) - ELAROS Signs New Partnership Deal with The University Of Huddersfield Funded by Grow Medtech ELAROS has signed a partnership deal with The University of Huddersfield and UScale to produce a measurement device to benefit LUTS sufferers. The project was brought together by the University’s Dr Luke Watson who is also a Technology Innovation Manager for
- [ELAROS appoints Jennifer McDonald as Project Manager for MammoScreen](https://www.elaros.com/elaros-appoints-jennifer-mcdonald-as-project-manager-for-mammoscreen/) - ELAROS appoints Jennifer McDonald as Project Manager for MammoScreen ELAROS is happy to announce that Jennifer Mcdonald has been appointed into the new role of ELAROS Project Manager of MammoScreen. Jennifer joins ELAROS with an MSc in Biotechnology and Microbiology from the University of York. Jennifer has developed professional laboratory skills alongside her education, covering topics such
- [ELAROS Works With Hallam Students During 'Scrum Week'](https://www.elaros.com/elaros-works-with-hallam-students-during-scrum-week/) - ELAROS Works With Hallam Students During 'Scrum Week' Students at Sheffield Hallam University built an additional module to one of ELAROS’ digital health products during the University’s annual ‘scrum week’. Scrum week is designed to give second year Software Engineers and Computer Scientists the chance to get involved in solving real world client problems, including
- [ELAROS Signs Strategic Partnership with Arquella Limited](https://www.elaros.com/elaros-signs-strategic-partnership-with-arquella-limited/) - ELAROS Signs Strategic Partnership with Arquella Limited ELAROS has signed a strategic partnership deal with Arquella Limited; a Sheffield-based company that has built a successful business delivering nurse call systems and falls prevention equipment to care homes. By pairing Arquella’s understanding of the care home sector with ELAROS’ expertise in digital health products, the two
- [ELAROS Appoints New Research and Development Manager](https://www.elaros.com/elaros-appoints-new-research-and-development-manager/) - ELAROS Appoints New Research and Development Manager ELAROS appoints Román Rocha Lawrence to the post of Research & Development Manager ELAROS is pleased to announce the appointment of Román Rocha Lawrence to the post of Research & Development Manager which he will begin at the company on the 1st of August 2020.Román joined ELAROS in July
- [ELAROS gives talk at annual Research Seminars at University of Sheffield](https://www.elaros.com/talk-at-annual-research-seminars/) - ELAROS gives talk at annual Research Seminars at University of Sheffield On Monday, ELAROS colleagues visited the University of Sheffield to talk to a group of Bioengineering students as part of their ‘Research Seminars’ module, kindly organised by Professor Chris Holland.The talk consisted of our CEO, Professor Paul O’Brien telling the students more about the origins
- [ELAROS to Kick-off Innovate UK project](https://www.elaros.com/elaros-to-kick-off-innovate-uk-project/) - ELAROS to kick-off Innovate UK project centred around urology ELAROS is pleased to kick-off an Innovate UK project today to further the development of our innovative Digital Bladder Diary; a hand-held device designed to help the growing number of men and women in the UK that suffer from bladder problems. This project will place the bladder
- [ELAROS Director of R&D features in the AHSN Network 'Meet the Innovator' interview series](https://www.elaros.com/elaros-director-of-rd-features-in-the-ahsn-network-meet-the-innovator-interview-series/) - ELAROS Director of R&D features in the AHSN Network 'Meet the Innovator' interview series ELAROS’ director of Research and Development and part-time Research Fellow at the University of Leeds, Román Rocha Lawrence, was interviewed for the AHSN Network ‘Meet the Innovator’ interview series. The interview was around the innovation of the C19-YRS platform collaboratively launched
- [ELAROS launches C19-YRS digital platform in Australia](https://www.elaros.com/digital-c19-yrs-launches-in-australia/) - Digital C19-YRS launches in Australia ELAROS is pleased to announce that University of Sydney are ELAROS’ first international client outside of the United Kingdom to adopt our digital C19-YRS platform as part of a research study on Long Covid.The study will run for 12 months initially, starting in June 2023.We expect to share more progress
- [Celia Hobbs joins ELAROS for Software Quality Assurance Internship](https://www.elaros.com/celia-hobbs-joins-elaros-for-software-quality-assurance-internship/) - Celia Hobbs joins ELAROS for Software Quality Assurance Internship ELAROS has selected Celia Hobbs to joins the company for the Summer Internship Programme in the role of Software Quality Assurance Intern. Celia is a recent graduate from The University of Sheffield, with a First Class MEng (Hons) in General Engineering and a specialisation in Medical Technologies. This
- [ELAROS attends the Medical Research Councils DiMen DTP Day Event](https://www.elaros.com/elaros-attends-the-medical-research-councils-dimen-dtp-day-event/) - ELAROS attends the Medical Research Councils DiMen DTP Day Event In July, two of the ELAORS colleagues Román Rocha Lawrence, R&D Manager, and Jennifer McDonald, PPIE Manager delivered an industry presentation at the University of York as part of the Medical Research Councils DiMeN DTP event. The presentation focused on careers in digital health and was
- [ELAROS Secures Funding from Santander Bank to Part-Fund New Graduate Trainee R&D Manager Role](https://www.elaros.com/elaros-secures-funding-from-santander-bank-to-part-fund-new-graduate-trainee-rd-manager-role/) - ELAROS Secures Funding from Santander Bank to Part-Fund New Graduate Trainee R&D Manager Role ELAROS has secured grant funding from Santander bank to part-fund a graduate trainee research & development manager role. The funding is provided through Santander Bank’s SME programme that is managed by The University of Sheffield. Our new Graduate Trainee R&D Manager will
- [ELAROS CEO Joins Panel in Grow MedTech Pump Prime Funding Competition](https://www.elaros.com/elaros-ceo-joins-panel-in-grow-medtech-pump-prime-funding-competition/) - ELAROS CEO Joins Panel in Grow MedTech Pump Prime Funding Competition ELAROS CEO, Professor Paul O’Brien, is delighted to have been asked by Grow MedTech to be one of the ‘Dragons’ in the Pump Prime Funding Competition pitches, that will take place in the afternoon session of the Conference in Leeds on the 6 December
- [Northamptonshire Healthcare NHS Foundation Trust adopt C19-YRS](https://www.elaros.com/northamptonshire-healthcare-nhs-foundation-trust-adopt-c19-yrs/) - Northamptonshire Healthcare NHS Foundation Trust adopt C19-YRS system ELAROS is delighted to welcome Northamptonshire Healthcare NHS Foundation Trust team to the rapidly growing cohort of NHS trusts using the C19-YRS. The C19-YRS team is thrilled with the addition of these advanced and highly respected Long COVID centres, which are leaders in their field. These additions
- [Opinion piece published in the British Medical Journal](https://www.elaros.com/opinion-piece-published-in-the-british-medical-journal/) - Opinion piece published in the British Medical Journal Published on the 10th of August 2023 in the British Medical Journal doi: 10.1136/bmj.p1816 ‘Digital interactive patient reported outcome measures for long termconditions’ The authors of the article include Dr Manoj Sivan (Associate Clinical Professor and Honorary Consultant at Leeds Institute of Rheumatic and Musculoskeletal Medicine, University
- [Somerset NHS Trust adopt C19-YRS](https://www.elaros.com/somerset-nhs-trust-adopt-c19-yrs/) - Somerset NHS Foundation Trust adopt C19-YRS system ELAROS is delighted to welcome Somerset NHS Foundation Trusts team to the rapidly growing cohort of NHS trusts using the C19-YRS. The C19-YRS team is thrilled with the addition of these advanced and highly respected Long COVID centres, which are leaders in their field. These additions are also
- [Oscar Petherick Joins Elaros on The Company's Summer Placement Programme](https://www.elaros.com/elaros-and-the-university-of-leeds-press-release-c19-yrs/) - Oscar Petherick Joins Elaros on The Company's Summer Placement Programme ELAROS is pleased to announce that the company will be hosting a University of Sheffield student for the next two weeks as part of our company’s summer placement programme.Oscar Petherick is a final-year Bioengineering Masters Degree Student at The University of Sheffield, specialising in Tissue
- [Virtual Clinic to Benefit LUTS Sufferers](https://www.elaros.com/virtual-clinic-to-benefit-luts-sufferers/) - Virtual Clinic to Benefit LUTS Sufferers The world’s first virtual assessment clinic in the field of Lower Urinary Tract Symptoms (LUTS) has been launched. ELAROS 24/7 is an innovative new way of carrying out initial assessment as well as the long term management and monitoring of patients with LUTS. LUTS refers to a range of
- [ELAROS Hosts Annual Winter Planning Day to Drive Innovation in 2025​](https://www.elaros.com/elaros-host-annual-winter-planning-day-2024/) - ELAROS Hosts Annual Winter Planning Day to Drive Innovation in 2025​ In early December, ELAROS held its Annual Winter Planning Day, bringing together our dedicated team alongside PhD researchers Bárbara Silva-Passadouro (University of Leeds) and Owain Medford (University of Huddersfield), as well as our Neu-Restore Scientific Director, Thomas Richards.The day began with a strategic session focused
- [ELAROS Hosts Annual Winter Planning Day to Drive Innovation in 2026](https://www.elaros.com/elaros-hosts-annual-winter-planning-day-to-drive-innovation-in-2026/) - ELAROS Hosts Annual Winter Planning Day to Drive Innovation in 2026 The ELAROS team came together for our annual Winter Planning Day, an important moment for reflection, collaboration, and shaping our strategy for 2026 and beyond.The morning opened with a presentation from Blesson Ezra who shared progress from our South Yorkshire Innovation Programme wearables project
- [Michalina Gers and Scarlett Shaw Join ELAROS as Software Quality Assurance Interns](https://www.elaros.com/michalina-gers-and-scarlett-shaw-join-elaros-as-software-quality-assurance-interns/) - Michalina Gers and Scarlett Shaw Join Elaros as Software Quality Assurance Interns In May, Michalina Gers and Scarlett Shaw joined ELAROS for a Software Quality Assurance Internship to support the advancement of our new NROL project and the Dysphagia Guide. Both Michalina and Scarlett are in their final year of a BSc in Computer Science with
- [ELAROS attends Software Engineering Showcase at Sheffield Hallam University](https://www.elaros.com/somerset-nhs-trust-adopt-c19-yrs-copy/) - ELAROS attends Software Engineering Showcase at Sheffield Hallam University Last week, ELAROS colleagues Henry Robinson, Toby Boud and Oliwia Zwara had the pleasure of attending the Sheffield Hallam University Computer Science and Software Engineering Student Showcase.This module has been part of a longstanding collaboration for ELAROS, where we provide a brief to three different groups
- [C19-YRS becomes the first Clinically Validated Outcome Measure for use in Long COVID Patients](https://www.elaros.com/c19-yrs-becomes-the-first-clinically-validated-outcome-measure-for-use-in-long-covid-patients/) - C19-YRS becomes the first Clinically Validated Outcome Measure for use in Long COVID Patients ELAROS is pleased to announce on behalf of our C19-YRS clinical partners the first global study that examines the psychometric properties of an outcome measure in patients with Post COVID Syndrome (Long COVID). In this sample of patients, the C19-YRS was
- [Ambitious Plans for ELAROS In 2016 Following Fundraising](https://www.elaros.com/ambitious-plans-for-elaros-in-2016-following-fundraising/) - Ambitious Plans for ELAROS In 2016 Following Fundraising ELAROS 24/7 Limited, a provider of innovative digital health solutions for the management and monitoring of people with long-term conditions, has closed its second investment round with £584,000 to take the business forward in 2016. The investment is made up of £100,000 from the Big Venture Challenge,
- [ELAROS and Leeds Long COVID team leads webinar hosted by Yorkshire and Humber AHSN](https://www.elaros.com/elaros-and-leeds-long-covid-team-leads-webinar-hosted-by-yorkshire-and-humber-ahsn/) - ELAROS and Leeds Long COVID team leads webinar hosted by Yorkshire and Humber AHSN On the 25th January ELAROS was involved in the first in a series of webinars covering the C19-YRS. The Webinar began with ELAROS partners who covered: the story of Long COVID so far and the NHS response (Dr Melissa Heightman –
- [C19-YRS featured on ITV News and BBC News North West](https://www.elaros.com/c19-yrs-featured-on-itv-news-and-bbc-news-north-west/)
- [ELAROS to part-fund a PhD post at the University of Huddersfield](https://www.elaros.com/elaros-to-part-fund-a-phd-post-at-the-university-of-huddersfield/) - ELAROS to part-fund a PhD post at the University of Huddersfield ELAROS is happy to announce its strategic partnership with the University of Huddersfield (UoH) to start work on the development of the Smart Hydration Coaster. As part of this agreement, ELAROS will part-fund a new PhD position at the University that will take the
- [ELAROS Appoints New Graduate Trainee Technology Development Manager](https://www.elaros.com/oscar-petherick-joins-elaros-on-the-companys-summer-placement-programme/) - ELAROS Appoints New Graduate Trainee Technology Development Manager ELAROS is pleased to announce the appointment of Gabriel Clarkson as the company’s Graduate Trainee Technology Development Manager.Gabriel has recently graduated from The University of Sheffield with First Class honours in Information Technology Management for Business BSc. This included a year in industry at Siemens Industrial Turbomachinery
- [ELAROS and Leeds Long COVID Team win at the Medipex Innovation Awards](https://www.elaros.com/elaros-and-leeds-long-covid-team-win-at-the-medipex-innovation-awards/) - ELAROS and Leeds Long COVID Team win at the Medipex Innovation Awards ELAROS is proud to announce that we along with our partners – Leeds Teaching Hospitals NHS Foundation Trust – were winners this afternoon in the ‘Management of Long Term Conditions’ category. We hope that the award will shine a bright light upon the
- [ELAROS host a 'Building a Long Covid Service' Webinar](https://www.elaros.com/elaros-host-a-building-a-long-covid-service-webinar/) - ELAROS host webinar on "Building a Long Covid Service" On the 26th of June ELAROS hosted a webinar to showcase how NHS MDT services are evolving to build a legacy from Long Covid to support patients in primary, community, and care at-home across a range of conditions.During this webinar, Jeremy Gee from Airedale and Bradford
- [Health Education England Launch Dysphagia Learning Platform](https://www.elaros.com/health-education-england-launch-dysphagia-learning-platform/) - Health Education England Launch Dysphagia Learning Platform Health Education England e-Learning for Healthcare (HEE e-LfH) has worked in partnership with Sheffield Teaching Hospitals NHS Foundation Trust, Royal College of Speech and Language Therapists and industry experts to develop the Dysphagia Guide e-learning resource for those working with people living with dysphagia. Elaros is proud to
- [Psychometric analysis of the modified Covid-19 Yorkshire Rehabilitation Scale](https://www.elaros.com/psychometric-analysis-of-the-modified-covid-19-yorkshire-rehabilitation-scale/) - Psychometric analysis of the modified C19-YRSm in a prospective multicentre study Published on the 3rd of January 2024 doi: 10.1101/2023.12.22.23300424‘Psychometric analysis of the modified Covid-19 Yorkshire Rehabilitation Scale (C19-YRSm) in a prospective multicentre study’The abstract of the article and summary points can be read here, but for the full article, please follow any of the
- [ELAROS 24/7 Wins Prestigious Bionow Award](https://www.elaros.com/elaros-24-7-wins-prestigious-bionow-award/) - ELAROS 24/7 Wins Prestigious Bionow Award ELAROS 24/7, an innovative new service that improves the initial assessment, diagnosis and triaging of patients with Lower Urinary Tract Symptoms (LUTS), has won the Innovative Ageing of the Year Award at the Bionow Annual Awards 2013. ELAROS 24/7’s Deputy Chairman, Martin Levermore MBE collected the award, sponsored by
- [ELAROS host PPIE workshops as part of MammoScreen Project in Lisbon, Portugal](https://www.elaros.com/elaros-host-ppie-workshops-as-part-of-mammoscreen-project-in-lisbon-portugal/) - ELAROS host PPIE workshops as part of MammoScreen Project in Lisbon, Portugal In May 2024, ELAROS was lucky to join the rest of the MammoScreen Project partners in at the Champalimaud Foundation in Lisbon, Portugal for a bi-annual MammoScreen Consortium meeting. Multiple ELAROS colleagues including CEO Paul O’Brien, Jennifer McDonald, Oscar Petherick, Toby Boud and
- [Blesson Ezra joins ELAROS Summer Placement Programme](https://www.elaros.com/blesson-ezra-joins-elaros-summer-placement-programme/) - Blesson Ezra joins ELAROS Summer 2023 Placement Programme ELAROS selected Blesson Ezra to join the company’s 2023 summer placement programme. Blesson is a MEng Bioengineering student at the University of Sheffield, specialising in Tissue Engineering and Biomaterials. Blesson has a keen interest in the future of digital healthcare, biomimetics and biomaterials. He’s particularly driven in
- [ELAROS sponsor British Society for Physical Rehabiliation Conference in Sheffield](https://www.elaros.com/elaros-sponsor-british-society-for-physical-rehabiliation-conference-in-sheffield/) - ELAROS sponsor British Society of Physical and Rehabiliation Medicine Conference in Sheffield ELAROS CEO,Professor Paul O’Brien, and Director of Research and Development, Román Rocha Lawrence, attended and sponsored the British Society of Physical & Rehabilitation Medicine (BSPRM) conference on the 3rd of July with ELAROS 24/7 Limited. They had a chance to meet many interesting
- [Abdul Raheem Nazir joins ELAROS Summer Placement Programme](https://www.elaros.com/abdul-raheem-nazir-joins-elaros-summer-placement-programme/) - Abdul Raheem Nazir joins ELAROS Summer Placement Programme ELAROS selected Abdul Raheem Nazir to join the company’s 2024 summer placement programme. Abdul is a final year BSc (Honours) Computer Science student at Sheffield Hallam University. His interest lie in seeking new opportunities and is dedicated to always learning and improving. His passion lies in creating
- [Digital Bladder Diary Could Save NHS millions](https://www.elaros.com/digital-bladder-diary-could-save-nhs-millions/) - Digital Bladder Diary Could Save NHS millions A new portable diary enabling patients to electronically record how often they go to the toilet could revolutionise the way doctors and clinicians treat common symptoms of the bladder and the lower urinary tract.The UroDiary, which is the only device of its kind in the world and looks
- [Former ELAROS Colleague Highly Commended in The Digital Health Awards](https://www.elaros.com/former-elaros-colleague-highly-commended-in-the-digital-health-awards-future-digital-leader-of-the-year-2019-category/) - Former ELAROS Colleague Highly Commended in The Digital Health Awards ELAROS are delighted that our former colleague, Dr Angel Jimenez-Aranda (now Digital Technology Lead at Devices for Dignity), was announced as Highly Commended in the Digital Health Awards ‘Future Digital Leader of the Year 2019’ category. Angel is a true pioneer and certainly a future leader
- [ELAROS appoints Technology and Business Development Manager](https://www.elaros.com/elaros-appoints-technology-and-business-development-manager/) - ELAROS to support a Joint PhD with the University of Leeds, the University of Manchester and the University of Liverpool ELAROS’s Executive Management Team has appointed Gabriel Clarkson to the position of Technology & Business Development Manager. Gabriel started with ELAROS a year ago (today) as our Graduate Trainee Technology Manager and successfully completed the
- [ELAROS and the C19-YRS recommended in newly published NHS Long COVID guidance](https://www.elaros.com/elaros-and-the-c19-yrs-recommended-in-newly-published-nhs-long-covid-guidance/) - ELAROS and the C19-YRS recommended by NHS England in newly published NHS Long COVID guidance
- [ELAROS appoints Business and Healthcare Analyst](https://www.elaros.com/elaros-appoints-business-and-healthcare-analyst/) - ELAROS appoints Business and Healthcare Analyst ELAROS is happy to announce that Henry Robinson has started with ELAROS full-time in the new role of Business & Healthcare Analyst. Henry has just completed an MSc in Healthcare Analytics and Artificial Intelligence at Sheffield Hallam University, for which he was awarded a distinction. Henry’s master’s degree explores
- [ELAROS accepted into the DBT Digital Health Playbook](https://www.elaros.com/elaros-accepted-into-the-dbt-digital-health-playbook/) - ELAROS accepted into the Department of Business and Trade Digital Health Playbook ELAROS is thrilled to announce that we have been accepted into the prestigious Digital Health Playbook hosted by the Department for Business and Trade !With over 180 UK innovators and exporters, the Digital Health Playbook is the gateway to the UK’s Healthtech innovation.
- [ELAROS CEO Invited to Present at the 2nd National Hydration Network Conference](https://www.elaros.com/elaros-ceo-invited-to-present-at-the-2nd-national-hydration-network-conference/) - ELAROS CEO Invited to Present at the 2nd National Hydration Network Conference ELAROS is pleased to have its CEO, Paul O’Brien, invited to present at the second National Hydration Network Conference in London tomorrow on the 17th of September, 2019. The presentation will focus on the implementation of our hydration management and monitoring app for care
- [ELAROS Appoints Scientific Director for New Innovate UK Project](https://www.elaros.com/elaros-appoints-scientific-director-for-new-innovate-uk-project/) - ELAROS Appoints Scientific Director for New Innovate UK Project ELAROS is delighted to announce that Dr Thomas Richards will join the team from the 1st April 2022, in the new role of – Scientific Director of Neu-Restore. Thomas will lead the scientific side of our work on our recently awarded £286,000 funded Innovate UK project. Thomas
- [ELAROS Appoints Román Rocha Lawrence as Graduate Trainee Research & Development Manager](https://www.elaros.com/elaros-appoints-roman-rocha-lawrence-as-graduate-trainee-research-development-manager/) - ELAROS Appoints Román Rocha Lawrence as Graduate Trainee Research & Development Manager ELAROS is pleased to appoint Román Rocha Lawrence as our new Graduate Trainee Research & Development Manager. He will manage a number of ELAROS projects and support the development of the company’s R&D portfolio. Román has just graduated from The University of Sheffield with
- [New Partnerships and Approaches to Health in the UK: The Case of ELAROS](https://www.elaros.com/new-partnerships-and-approaches-to-health-in-the-uk-the-case-of-elaros/) - New Partnerships and Approaches to Health in the UK: The Case of ELAROS ELAROS 24/7 Ltd participates in the workshop Entrepreneurial University, Engaged Industry & Active Government: Triple Helix Opportunities, hosted by the University of Surrey. 
- [ELAROS appoints Research and Development Manager](https://www.elaros.com/elaros-appoints-research-and-development-manager/) - ELAROS appoints Research and Development Manager ELAROS is happy to announce that Oscar Petherick has been promoted to the role of Research and Development Manager at ELAROS. This promotion marks Oscar’s 9 month anniversary with ELAROS, joining shortly after finishing his Masters in Bioengineering from the University of Sheffield. Oscar first joined ELAROS as Graduate
- [Celine Amadou-Douah to join ELAROS Summer Placement Programme](https://www.elaros.com/elaros-continues-summer-placement-programme/) - Celine Amadou-Douah to join ELAROS Summer Placement Programme ELAROS has selected Celine Amadou-Douah to join the company’s 2021 summer placement programme. Celine is a University of Sheffield student, studying for an MSc(Eng) in Advanced Control and Systems Engineering. Last year Celine graduated from the University of Sheffield with a BEng in Bioengineering. ELAROS is looking
- [ELAROS Wins Funding from Innovate UK](https://www.elaros.com/elaros-wins-funding-from-innovate-uk-2/) - ELAROS Wins Funding from Innovate UK ELAROS has won funding from Innovate UK to further the development of its innovative digital bladder diary. The bladder diary is a hand-held device designed to help the growing number of men and women in the UK that suffer from bladder problems. This project will place the bladder diary in
- [6th year of the annual Summer Placement Programme](https://www.elaros.com/6th-year-of-the-annual-summer-placement-programme/) - ELAROS begin 2024 Annual Summer Placement Programme ELAROS is excited to begin the 6th year of our annual Summer Placement Programme. 2024 marks a special time for the company as we are excited to have 4 placement student join us this year, who will be working in Digital Marketing or Software Quality Assurance and focused
- [ELAROS appoints Regulatory Affairs and IT Manager](https://www.elaros.com/elaros-appoints-regulatory-affairs-and-it-manager/) - ELAROS appoints Regulatory Affairs and IT Manager ELAROS is happy to announce that Henry Robinson has taken on the new role of Regulatory Affairs and IT Manager at Elaros. Before joining Elaros full time, Henry had recently completed an MSc in Healthcare Analytics and Artificial Intelligence at Sheffield Hallam University, for which he was awarded
- [Oliwia Zwara to join ELAROS Summer Placement Programme](https://www.elaros.com/oliwia-zwara-to-join-elaros-summer-placement-programme/) - Oliwia Zwara to join ELAROS Summer 2022 Placement Programme ELAROS has selected Oliwia Zwara to join the company’s 2022 summer placement programme. Oliwia is a University of Sheffield student, studying for a MEng Bioengineering and specialising in Tissue Engineering and Biomaterials. Oliwia has previously engaged with the Global Engineering Challenge, designing a medical device for
- [Iona Doyle joins ELAROS for Digital Marketing Internship](https://www.elaros.com/iona-doyle-joins-elaros-for-digital-marketing-internship/) - Iona Doyle selected for role of Digital Marketing Intern at ELAROS ELAROS selected Iona Doyle to join companies Summer Internship Programme specialising in Digital Marketing Iona is a recent MEng Bioengineering graduate from the The University of Sheffield, specialising in Tissue Engineering and Biomaterials. She was particularly drawn to the multidisciplinary nature of the field,
- [ELAROS Signs New Partnership Deal with The University of West London to Deliver Improved Hydration for Older People](https://www.elaros.com/elaros-signs-new-partnership-deal-with-the-university-of-west-london-to-deliver-improved-hydration-for-older-people/) - ELAROS Signs New Partnership Deal with The University of West London to Deliver Improved Hydration for Older People The University of West London (UWL) signs new partnership deal with ELAROS to digitise its hydration management tool, I-Hydrate, for care homes. More than 400,000 people live in care homes in the UK and residents are vulnerable to
- [University of Sheffield Software Systems & Internet Technology MSc Student Joins the ELAROS For the Summer](https://www.elaros.com/university-of-sheffield-software-systems-internet-technology-msc-student-joins-the-elaros-team-for-the-summer/) - University of Sheffield Software Systems & Internet Technology MSc Student Joins the ELAROS For the Summer ELAROS is pleased to welcome MSc student in Software Systems & Internet Technology at The University of Sheffield, Qidi Wu, to the team for the summer. Qidi is undertaking his summer assignment with ELAROS as part of an agreement with
- [ELAROS Wins Innovation Voucher for Cyber Security Project](https://www.elaros.com/elaros-wins-innovation-voucher-for-cyber-security-project/) - ELAROS Wins Innovation Voucher for Cyber Security Project ELAROS has been awarded £5,000 from Innovate UK for a cyber security project with the University of Bradford. Funded through the Innovation Voucher scheme, the project focuses on how ELAROS can best protect their customer data. Innovate UK Innovation Vouchers provide funding to support businesses in working with
- [ELAROS to support a Joint PhD with the University of Leeds, the University of Manchester and the University of Liverpool](https://www.elaros.com/elaros-to-support-a-joint-phd-with-the-university-of-leeds-the-university-of-manchester-and-the-university-of-liverpool/) - ELAROS to support a Joint PhD with the University of Leeds, the University of Manchester and the University of Liverpool ELAROS is delighted to be able to announce that we are the iCASE partner (private sector partner) to this new and significant funded PhD opportunity with our partners at the University of Leeds, the University
- [ELAROS wins Phase 2 funding for Open-OH project](https://www.elaros.com/elaros-wins-phase-2-funding-for-open-oh-project-copy/) - ELAROS wins Phase 2 funding through Innovate UKs Small Business Research Initiative for Open-OH project On the 15th of April 2024 ELAROS was named one of the five winners nationally of the SBRI project funded by the Department for Work and Pensions (DWP) and Department of Health and Social Care.This funding will support ELAROS to
- [ELAROS gives Open OH elevator pitch at SBRI Show and Tell Event](https://www.elaros.com/sbri-show-and-tell-event/) - ELAROS presents Open OH elevator pitch at SBRI Show and Tell event Last week, two of our colleagues Toby Boud and Oscar Petherick had the opportunity to attend a Show and Tell event organised for the participants of the SBRI funding call ‘Increasing access to and capacity in Occupational Health’. The event took place at
- [Paper On ELAROS and Sheffield Teaching Hospital's Dysphagia Guide App for Care Homes Published](https://www.elaros.com/paper-on-elaros-sheffield-teaching-hospitals-dysphagia-guide-app-for-care-homes-published/) - Paper On ELAROS and Sheffield Teaching Hospital's Dysphagia Guide App for Care Homes Published ELAROS is pleased to share an important paper published on the 15th of August regarding another product that ELAROS is collaborating on for the care home sector, this time with Sheffield Teaching Hospitals NHS Foundation Trust. The product development was funded by
- [ELAROS appoints Daniel Weatherill as Trainee Management Accountant](https://www.elaros.com/elaros-appoints-daniel-weatherill-as-trainee-management-accountant/) - ELAROS appoints Daniel Weatherill as Trainee Management Accountant ELAROS is happy to announce that Daniel Weatherill has been appointed into the new role of ELAROS Trainee Management Accountant. Dan is a recent graduate from The University of Sheffield, having studied Business Management. He particularly enjoyed the maths and data side of his course, exploring how
- [ELAROS Forms Strong Partnership to Address Sleep Issues in Children](https://www.elaros.com/strong-partnership-to-address-children-sleep-issues/) - ELAROS Forms Strong Partnership to Address Sleep Issues in Children ELAROS Ltd is working in partnership with The Children’s Sleep Charity a national award winning charity based in Yorkshire and Sheffield Children’s Hospital on a pioneering approach to support self-management and clinical decision making in primary care, aligned to better utilisation of limited resources in
- [ELAROS CEO invited to demonstrate at 2019 NCF Conference](https://www.elaros.com/elaros-ceo-invited-to-2019-ncf-conference-to-demonstrate-elaros-products/) - ELAROS CEO Invited To 2019 NCF Conference to Demonstrate ELAROS CEO invited to 2019 National Care Forum Conference to demonstrate ELAROS care home products.We are pleased to have ELAROS CEO, Professor Paul O’Brien, invited to the 2019 National Care Forum (NCF) Conference to demonstrate a range of ELAROS’ care home products, namely: the Digital Bladder
- [ELAROS to Sponsor Asthma Research Ph.D Studentship](https://www.elaros.com/elaros-to-sponsor-asthma-research-ph-d-studentship/) - ELAROS to Sponsor Asthma Research Ph.D Studentship ELAROS is pleased to announce its sponsorship of a Ph.D studentship in collaboration with the University of Sheffield, the Sheffield Pulmonary Vascular Disease Unit and Sheffield Children’s Hospital. Professor Paul O’Brien CEO of Elaros remarked, “We are delighted to be providing sponsorship for this studentship which will help
- [ELAROS and Leeds NHS Trust announce national long Covid webinar](https://www.elaros.com/elaros-and-leeds-nhs-trust-announce-national-long-covid-webinar/) - ELAROS and Leeds NHS Trust announce National Long COVID webinar On the 20th September ELAROS will be hosting another webinar in the series covering the C19-YRS, titled “NHS long COVID guidance 2022: How ELAROS’ platform can support clinics” This webinar will provide an overview of PROMs used in the Leeds LC clinic and how ELAROS’
- [ELAROS appoints Toby Boud as Deputy Project Manager for Open OH](https://www.elaros.com/elaros-appoints-toby-boud-as-deputy-project-manager-for-open-oh/) - ELAROS appoints Toby Boud as Deputy Project Manager for Open OH ELAROS is absolutely delighted to announce that Toby has been appointed into the new role of Deputy Project Manager of Open OH. Toby is a recent graduate from The University of Sheffield, with a MEng in Biomaterial Science and Engineering. This is an interdisciplinary degree
- [ELAROS Welcome Arianna Conti for Rover Horizon 2020’s Student Placement](https://www.elaros.com/elaros-welcomed-arianna-conti-for-rover-horizon-2020s-student-placement/) - ELAROS Welcomed Arianna Conti for Rover Horizon 2020’s Student Placement ELAROS was delighted to welcome Arianna Conti, a Master’s student in Management Engineering from the Università degli Studi di Firenze, for a six-month placement as part of the ROVER 2020 EU Project. This opportunity followed the signing of a Memorandum of Understanding between ELAROS and
- [ELAROS Secures SBRI Healthcare Grant for Stroke Rehabilitation Project - NROL](https://www.elaros.com/elaros-secures-sbri-healthcare-grant-for-stroke-rehabilitation-project-nrol-copy/) - ELAROS Secures SBRI Healthcare Grant for Stroke Rehabilitation Project - NROL ELAROS is thrilled to announce the success of a new project award from SBRI Healthcare’s Stroke Grant (Competition 26, Phase 3). The project is led by East Lancashire Hospitals NHS Trust in collaboration with Lancaster University, Health Innovation North West Coast, SameYou, Lancashire and
- [Ben MacKellar Joins Elaros as Software Development Intern](https://www.elaros.com/ben-mackellar-joins-elaros-as-software-development-intern/) - Ben MacKellar Joins Elaros as Software Development Intern In March, Ben MacKellar joined ELAROS for a Software Development Internship to support the advancement of The Dysphagia Guide, one of our latest innovations. Ben holds an MSc in Software Engineering from the University of Westminster and an MEng in Bioengineering from The University of Sheffield. With
- [Connecting with the Next Generation of Bioengineers at The University of Sheffield](https://www.elaros.com/connecting-with-the-next-generation-of-bioengineers-at-the-university-of-sheffield/) - Connecting with the Next Generation of Bioengineers at The University of Sheffield On Monday, ELAROS colleagues had the pleasure of visiting The University of Sheffield to speak with Bioengineering students as part of their Research Seminars module, kindly organised by Professor Chris Holland. Professor Paul O’ Brien opened the session with an insightful overview of
- [ELAROS Hosts Webinar on Digitally Supporting ME/CFS and Long COVID Services](https://www.elaros.com/elaros-hosts-webinar-on-digitally-supporting-me-cfs-and-long-covid-services/) - ELAROS Hosts Webinar on Digitally Supporting ME/CFS and Long COVID Services On Wednesday, 5th February, ELAROS hosted a webinar on Digitally Supporting ME/CFS and Long COVID Services, bringing together key experts at a crucial time for the ME/CFS and Long COVID communities.The event featured a presentation from Sarah Tyson (University of Manchester/ME Association) and Russell
- [ELAROS Strengthens Long-Standing Partnership with Umbria Bioengineering Technologies in Italy](https://www.elaros.com/elaros-strengthens-long-standing-partnership-with-umbria-bioengineering-technologies-in-italy/) - ELAROS Strengthens Long-Standing Partnership with Umbria Bioengineering Technologies in Italy In January, a team of nine ELAROS colleagues travelled to Italy for a four-day programme to meet with one of our longest-standing partners, Umbria Bioengineering Technologies—a leading Italian university spin-out with whom we have collaborated for over seven years.Our partnership has been instrumental in delivering
- [ELAROS host a 'Building a Long Covid Service Legacy: Episode 2' Webinar](https://www.elaros.com/elaros-host-a-building-a-long-covid-service-legacy-episode-2-webinar/) - ELAROS host webinar on "Building a Long Covid Service: Episode 2" On the 6th of November ELAROS hosted their second webinar in the ‘Building a Long Covid Service Legacy’ series to aid NHS services to support patients in primary, community, and care at-home across a range of long-term conditions.This webinar is our 5th international webinar
- [ELAROS welcomes back Blesson Ezra to the team](https://www.elaros.com/elaros-welcomes-back-blesson-ezra-to-the-team/) - ELAROS welcomes back Blesson Ezra to the team ELAROS has welcomed back Blesson Ezra after his completion of the company’s 2023 summer placement programme. Blesson graduated from the University of Sheffield, this year with an MEng in Bioengineering specialising in Tissue Engineering and Biomaterials. He completed his final project in the natural material, on spider
- [ELAROS Innovate UK Care Home Research Project Draws To A Close](https://www.elaros.com/monitoring-hydration-in-care-home-residents-using-the-hydr8-app/) - ELAROS Innovate UK Care Home Research Project Draws To A Close ELAROS has recently completed a six-month project looking at how digital technology could be used to help deliver care to people living in care homes. The project, funded for six months by Innovate UK, aimed to identify the factors that should be considered when developing
- [ELAROS Sponsors Clinical Post Covid Society’s 2025 Conference](https://www.elaros.com/elaros-sponsors-clinical-post-covid-societys-2025-conference/) - ELAROS Sponsored Clinical Post Covid Society’s 2025 Conference In March 2025, ELAROS proudly sponsored the Clinical Post Covid Society’s Annual Conference in Birmingham in. Our Director of Research & Development, Román Rocha Lawrence, delivered one of the closing sessions titled “Looking to the Future”, which featured three impactful case studies from our C19-YRS platform: Scaling
- [Davide Righi joins ELAROS as Commercial R&D Manager](https://www.elaros.com/davide-righi-joins-elaros-as-commercial-rd-manager/) - Davide Righi joins ELAROS as Commercial R&D Manager On Monday 28th July, we welcomed Davide Righi back to ELAROS for his year in industry, having previously joined ELAROS in the summer of 2024 as a Digital Marketing Intern. Davide impressed on his first with the company, so we are delighted to welcome him back for
- [ELAROS featured in European Journal on £8 Billion Annual Cost of Long Covid](https://www.elaros.com/elaros-featured-in-european-journal-study-on-8-billion-annual-cost-of-long-covid/) - ELAROS is Featured in a European Journal on £8B Annual Cost of Long Covid We are pleased to share our latest publication as co-authors in the European Journal of Health Economics as part of the NIHR funded LOCOMOTION study alongside colleagues at University of Leeds and University of Oxford. You can access the full publication
- [ELAROS Secures SBRI Healthcare Grant for Mental Health Workplace Adjustments Project](https://www.elaros.com/elaros-secures-sbri-healthcare-grant-for-mental-health-workplace-adjustments-project/) - ELAROS Secures SBRI Healthcare Grant for Mental Health Workplace Adjustments Project ELAROS is thrilled to be named one of just nine national winners of the SBRI Healthcare competition, supported by the Health Innovation Network! Our winning project, Adjustments by Open-OH, is focused on delivering work-related mental health interventions for people living with long-term conditions.We’re proud
- [Román Rocha Lawrence Speaks at Clinical Post Covid Society Conference](https://www.elaros.com/roman-rocha-lawrence-speaks-at-clinical-post-covid-society-conference/) - Román Rocha Lawrence Speaks at Clinical Post Covid Society Conference In March, Román Rocha Lawrence, Director of Research & Development at ELAROS, had the honour of speaking at the Clinical Post Covid Society’s annual conference. His session showcased the collaborative work between ELAROS, the University of Leeds, Airedale NHS Foundation Trust, BACME, and the ME
- [ROVER: ELAROS delivers an industrial visit to University of Florence](https://www.elaros.com/rover-elaros-delivers-an-industrial-visit-to-university-of-florence/) - ROVER: ELAROS delivers an industrial visit to University of Florence ELAROS Director of Research and Development, Román Rocha Lawrence, delivered a two week industrial visit to the Università degli Studi di Firenze as part of ELAROS 24/7 Limited European Horizon 2020 ROVER (Reliable Technologies and Models for Verified Wireless Body-centric Transmission and Localisation) project. We’d like
- [Mammoscreen launches the Hereditary Breast Cancer Questionnaire](https://www.elaros.com/mammoscreen-launches-the-hereditary-breast-cancer-questionnaire/) - MammoScreen launches the Hereditary Breast Cancer Questionnaire In August 2023, the Hereditary Breast Cancer Questionnaire was launched as part of the MammoScreen project that ELAROS is a part of. ELAROS worked on creating the questionnaire which had an aim of exploring the vital domains of Hereditary Breast Cancer, and listen to womans’ experiences on: Psychological effect: Understanding the
- [MAMMOSCREEN takes part in the first Annual Meeting of the Cancer Mission Cluster](https://www.elaros.com/mammoscreen-takes-part-in-the-first-annual-meeting-of-the-cancer-mission-cluster/) - MAMMOSCREEN takes part in the first Annual Meeting of the Cancer Mission Cluster “Prevention and early detection (Screening)” The first annual meeting of the “Prevention and early detection (screening)” Cluster of projects was held on September 7th in San Sebastian, Spain. In late 2022, in response to the Horizon Europe call titled ”Develop new methods and
- [ELAROS joins MammoScreen in Breast Cancer webinar](https://www.elaros.com/elaros-joins-mammoscreen-in-breast-cancer-webinar/) - ELAROS joins MammoScreen in organising webinar “Shaping the future of Breast Cancer screening: introducing the MammoScreen project” The first MammoScreen Webinar with Patient Advocates and Patient Advocay Groups was held on 4th September 2023. The primary purpose of this first MammoScreen Project Webinar was to facilitate comprehensive knowledge dissemination and collaborative discussions around the MammoScreen project. Our aim was
- [MAMMOSCREEN joins the cancer “Prevention and early detection (Screening)” cluster of EU funded projects](https://www.elaros.com/mammoscreen-joins-the-cancer-prevention-and-early-detection-screening-cluster-of-eu-funded-projects/) - MAMMOSCREEN joins the cancer “Prevention and early detection (Screening)” cluster of EU funded projects It is with great pleasure that we announce that MAMMOSCREEN has joined the EU funded projects cluster on cancer “Prevention and early detection (Screening)”. Under the positive impulse given by European Union, funded projects that work on common research areas are
- [NHS Highland first in Scotland to adopt digital C19-YRS](https://www.elaros.com/nhs-highland-first-in-scotland-to-adopt-digital-c19-yrs/) - The Press and Journal Evening Express announce adoption of digital C19- YRS in NHS Highland‘I feel like I’m one of the lucky ones’: New long Covid service in Highlands gives hope for patientsKirstie’s Story Kirstie was left with “debilitating and frustrating” symptoms when she fell ill with long Covid. One of the worst problems was brain
- [ELAROS Achieve Cyber Essentials Plus Certification](https://www.elaros.com/elaros-achieve-cyber-essentials-plus-certification/) - ELAROS Achieve Cyber Essentials Plus Certification ELAROS has achieved the Cyber Essentials Plus certification, following a successful audit from third party cyber security experts. Cyber Essentials is a government backed scheme that aims to give companies protection against a wide variety of the most common cyber attacks. The basic level of Cyber Essentials involves self-assessment certification,
- [Neu-Restore Advisory Board Meeting held at University of Leeds](https://www.elaros.com/neu-restore-advisory-board-meeting/) - University of Leeds host Neu-Restore Advisory Board Meeting ELAROS were delighted to be hosted by Professor Samit Chakrabarty for the third Neu-Restore Advisory Board meeting at the University of Leeds. The meeting offered the chance to showcase the exciting developments being made by Samit’s research group. This included a presentation of the groups recent research
- [ELAROS and University of Leeds secure ESRC funded fellowship focused on Long Covid](https://www.elaros.com/elaros-and-university-of-leeds-secure-esrc-funded-fellowship-focused-on-long-covid/) - ELAROS and University of Leeds secure ESRC funding for a new research fellowship focused on our existing joint work around long Covid ELAROS is delighted to announced that we, alongside our partner, the University of Leeds, have secured funding from the Economic and Social Research Council (ESRC) to establish a research fellowship at the University
- [ELAROS and Leeds NHS Trusts win the Outstanding Collaboration with Industry award at the national AHSN Network Innovate Awards](https://www.elaros.com/elaros-and-leeds-nhs-trusts-win-the-outstanding-collaboration-with-industry-award-at-the-national-ahsn-network-innovate-awards/) - ELAROS, Leeds Community Healthcare, and Leeds Teaching Hospitals NHS Trust win the Outstanding Collaboration with Industry award at the national AHSN Network and NHS Confederation Innovate Awards ​ ELAROS is thrilled to announce that we, alongside our partners from Leeds Teaching Hospitals NHS Trust and Leeds Community Healthcare NHS Trust, have been awarded the Outstanding
- [Mi-Trial Launches Innovative New Clinical Trials App And Portal](https://www.elaros.com/mi-trial-launches-innovative-new-clinical-trials-app-and-portal/) - Mi-Trial Launches Innovative New Clinical Trials App And Portal To Improve Trial Participation And Outcomes
- [ELAROS Builds Links with China On Technology Trade Mission](https://www.elaros.com/elaros-builds-links-with-china-on-technology-trade-mission/) - ELAROS Builds Links with China On Technology Trade Mission Professor Paul O’Brien, ELAROS’ CEO, took part in the recent Northern Powerhouse Trade Mission to Beijing, China. The technology-focused mission was geared to high growth companies keen to make contacts and create business opportunities in developing Chinese sectors, in ELAROS’ case in Medical & Consumer Health Products. Organised
- [Digital C19-YRS Officially Launched](https://www.elaros.com/digital-c19-yrs-officially-launched/) - Digital platform to support patients coping with long covid goes live People with long covid could be monitored with the aid of a ground-breaking mobile phone app and clinical website. The system has been developed to help NHS rehabilitation teams manage the large number of people suffering from the debilitating effects of the illness. Patients

## Pages

- [ELAROS 24/7 Limited](https://www.elaros.com/) - ELAROS is a private digital health company, incubated by NHS organisations. We adopt a partnership approach to product development.
- [The Team](https://www.elaros.com/the-team/) - Meet the Team Prof. Paul O’BrienChief Executive Officer and Director Bio Prof. Paul O’BrienChief Executive Officer and Director Professor Paul O’ Brien was appointed CEO of ELAROS 24/7 in April 2012. Paul has held senior posts in the private sector (Chief Executive), local government (Chief Officer), health (Director in West Essex NHS Trust) and education
- [Mi-Trial B2B Brochures](https://www.elaros.com/mi-trial-b2b-brochures/) - Mi-Trial B2B Brochures Industry Academia
- [Evidence](https://www.elaros.com/evidence/) - Evidence Discover our latest scientific publications All of our healthcare solution are developed with leading clinicians, industry experts and active researchers in order to provide the highest standard of care, with most up to date healthcare information.Below, you can view the results of these fruitful collaborations in the form of: Awards Posters Publications Certifications Reports Webinars
- [Our Advisors](https://www.elaros.com/our-advisors/) - Meet our Advisors Matt AbramsPNP Digital Bio Matt AbramsDirector at Pipe and Piper Matt Abrams graduated from Sheffield Hallam University with a BSc (Hons) in Business Information Technology and later co-founded PNP Digital in 2012. Previously the Operations Director for a web design agency, Matt developed a range of skills and experience that finally led
- [Modern Slavery Statement](https://www.elaros.com/modern-slavery-statement/) - ELAROS Modern Slavery Statement Modern slavery is a crime and a violation of fundamental human rights. It takes various forms such as slavery, servitude, forced and compulsory labour, and human trafficking – all of which have in common the deprivation of a person’s liberty by another in order to exploit them for personal / commercial
- [Legal](https://www.elaros.com/legal/) - Legal ELAROS Privacy Policy ELAROS Modern Slavery Statement Contact Us If you’re interested in working with us, want to find out more, or have an idea for a collaboration, reach out! Email us: hello@elaros.com Follow us: Linkedin Instagram Facebook Youtube X-twitter Contact page
- [Privacy Policy](https://www.elaros.com/privacy-policy/) - ELAROS Privacy Policy 1. IntroductionWelcome to ELAROS 24/7 Limited’s (ELAROS) privacy policy.This privacy policy will tell you:How we look after personal data when you deal with us or visit our website at https://www.elaros.com (Our Website). If you use another app, website, or cloud-based software that we provide, please consult the relevant privacy policy for that
- [Open-OH](https://www.elaros.com/solutions/open-oh/) - Open-OH Open-OH is a mobile app designed to support people with Long Covid, ME/CFS, Fibromyalgia to gradually improve their day-to-day living at home and in the workplace.Open-OH brings together a range of useful features and resources to help people with their health, wellbeing, and functional capacity throughout their journey with their condition. It can also help
- [Autonom-e (for Organisations)](https://www.elaros.com/solutions/autonom-e-for-organisations/) - Autonom-e (for Organisations) A customisable digital solution for the remote assessment, triage, monitoring, management, rehabilitation and education of patients with a range of long-term conditions.Built on the award-winning, NHS recommended digital platform, C19-YRS, for the remote assessment, triage, monitoring, management, rehabilitation and research of a range of conditions.Developed with the NHS, available worldwide for clinical, research,
- [Autonom-e+ (for the Public)](https://www.elaros.com/solutions/autonom-e-for-the-public/) - Autonom-e+ for Long Covid & ME/CFS Built on the award-winning, NHS recommended digital platform, C19-YRS, for the remote assessment, triage, monitoring, management, rehabilitation and research of a range of conditions.Download the app for free from the app storeComplete the gold standard C19-YRS Long Covid assessmentComplete the popular FUNCAP27 tool, validated in ME/CFSTrack symptoms, exertion, and
- [News](https://www.elaros.com/news-and-updates/) - News NROL wins national collaboration award at Advancing Healthcare Awards 2026 Read More 25/06/2026 NROL Service Successfully commissioned in Lancashire & South Cumbria ICB Read More 01/05/2026 NeuroRehabilitation OnLine Service wins NHS Excellence award for Patient Involvement & Choice Read More 27/04/2026 A milestone for the NHS Neuro Rehabilitation OnLine (NROL) service Read More 24/02/2026
- [B2C Public Apps Available though ELAROS](https://www.elaros.com/public-apps-available-though-elaros/) - B2C Public Apps Available through ELAROS C19-YRS MEA Autonom-e App Links On mobile Click a link below or search for "autonom-e" in your app store Alternatively, on a computer Log into the web app through an internet browser (Microsoft Edge or Chrome is recommended) C19-YRS App Links On mobile Click a link below or search
- [Contact](https://www.elaros.com/contact/) - Contact Us For general enquiries, sales and technical support, get in touch! Email us: hello@elaros.com Follow us: Linkedin Instagram Facebook Youtube X-twitter Our Office +44 (0)114 286 6344 Electric WorksSheffield Digital Campus3 Concourse WaySheffieldS1 2BJ Review Let others know how we’re doing Leave us a review Forms Enter Your Details Below to Access Our Autonom-e
- [Careers](https://www.elaros.com/careers/) - Join the Team We’re growing, and we’re looking for talented individuals to join our team.Scroll down to see our open roles. Current Vacancies We don’t have any open roles at the moment but we do consider speculative applications, see below. Get in touch Send us a copy of your CV, with a covering email or
- [Mi-Trial Limited](https://www.elaros.com/solutions/mi-trial/) - Mi-Trial Limited Mi-Trial is a clinical trial companion system and app. It has been designed to meet the needs of both trial participants and those managing trials, with important benefits for the integrity of the trial that help all partners. There are two major components: the patient-facing app, and the portal from which the trial
- [The ME Association App](https://www.elaros.com/the-me-association-app/) - The ME Association App The ME Association’s app and Clinical Assessment Toolkit is available digitally through the autonom-e app.Register onto the ME Association app through the autonom-e app available on the app store Access the ME Association’s clinical assessment toolkit, co-developed with the ME community Generate clinical reports to share with health professionals, employers or relatives Access support
- [Autonom-e B2B Brochures](https://www.elaros.com/autonom-e-b2b-brochures/) - Autonom-e B2B Brochures Clinical Research Charity Stroke & Neuro Rehabilitation
- [C19-YRS (for the Public)](https://www.elaros.com/solutions/c19-yrs-for-the-public/) - C19-YRS (for the Public) Our NHS-recommended C19-YRS app is now available without a referral to a clinical service.Download the C19-YRS app directly from the App StoreComplete the gold standard C19-YRS and EQ-5D-5L assessmentsTrack symptoms, exertion, and goals each dayShare health reports with clinicians or your employerAccess translatable support resources produced by health organisations and charitiesContribute your data
- [C19-YRS (for Organisations)](https://www.elaros.com/solutions/c19-yrs-for-organisations/) - C19-YRS (for Organisations) An award-winning digital assessment and monitoring tool for managing individuals with Long COVID. Recommended by NHS England and NICECo-developed by patients, The University of Leeds, Leeds long Covid rehab team, and ELAROSA not-for-profit initiative for all NHS organisations Award-winning The world's first clinically validated, condition-specific PROM for Long COVID. Live in over
- [Projects](https://www.elaros.com/projects/) - Projects Open-OHWorkplace support for people with long-term conditions Neu-RestoreA new way to assess stroke Sleepy FoxSupporting children with sleep disorders Hydr8Better fluids monitoring for older population The Care Home Guide to DysphagiaImproving swallowing Contact Us If you’re interested in working with us, want to find out more, or have an idea for a collaboration, reach
- [The Care Home Guide to Dysphagia](https://www.elaros.com/solutions/the-care-home-guide-to-dysphagia/) - The Care Home Guide to Dysphagia A guide to managing care home residents with swallowing difficultiesDysphagia is a condition that affects the ability to swallow and affects many elderly people, including residents in care homes. The swallowing mechanism changes significantly as people age and its disruption can have long-range health consequences in older adults, including
- [Hydr8](https://www.elaros.com/solutions/hydr8/) - Hydr8 The Hydration Monitoring System for Care HomesDehydration in older people is among the top 10 reasons for hospital admission resulting in a significant financial impact on the healthcare system. Yet dehydration in older people can easily be prevented or treated with an appropriate hydration programme.Hydr8™ was developed by North Tyneside Clinical Commissioning Group and
- [Sleepy Fox](https://www.elaros.com/solutions/sleepy-fox/) - Sleepy Fox A pioneering mobile app to support the assessment of children with sleep disordersSleep is essential for human survival. Lack of adequate sleep leads to many detrimental health effects. Common behavioural sleep problems include difficulties falling asleep, an inability to maintain sleep and early morning awakenings. Evidence has shown that paediatric behavioural sleep programmes
- [Neu-Restore](https://www.elaros.com/solutions/neu-restore/) - A Digital Stroke Assessment and Management Platform for Better Quality Rehabilitation Neu-Restore™ is an Innovate UK funded project, which will deliver a digital hub for the management of the upper limb following stroke. This includes an app for stroke survivors and carers, and a web portal for physios and clinical staff.This hub is built around
- [Digital Bladder Diary](https://www.elaros.com/solutions/the-digital-bladder-diary/) - Digital Bladdar Diary An innovative way of carrying out the initial assessment, diagnosis and triaging of people with bladder conditions.At some point in their life two out of every three adults will have a bladder related problem, requiring a visit to their GP to identify the problem. Currently, people presenting to their GP with bladder
- [Solutions](https://www.elaros.com/solutions/) - Solutions Autonom-e (for Organisations)A customisable digital solution for the remote assessment, triage, monitoring, management, rehabilitation and education of patients with a range of long-term conditions. Autonom-e+ (for the Public)A customisable digital solution for the remote assessment, triage, monitoring, management, rehabilitation and education of patients with a range of long-term conditions. The ME Association AppA clinical
- [Outstanding Collaborators](https://www.elaros.com/supporters/) - Outstanding Collaborators Proud to collaborate and innovate with customers in the NHS and around the world Contact Us If you’re interested in working with us, want to find out more, or have an idea for a collaboration, reach out! Email us: hello@elaros.com Follow us: Linkedin Instagram Facebook Youtube X-twitter Contact page
- [Trusted Partners](https://www.elaros.com/collaborators/) - Trusted Partners We are proud to work with over 70 healthcare organisations and Universities in the NHS and around the World Contact Us If you’re interested in working with us, want to find out more, or have an idea for a collaboration, reach out! Email us: hello@elaros.com Follow us: Linkedin Instagram Facebook Youtube X-twitter Contact
- [How We Work](https://www.elaros.com/how-we-work/) - How We Work We love collaborating to bring together research, healthcare and industry. Whether we are providing the NHS with software solutions, aiding specific research goals, or funding and delivering early stage projects, we believe in delivering better health outcomes through innovative and personalised technologies. See how we work in each of the areas below.
- [About Us](https://www.elaros.com/aboutus/) - About Us How We WorkRead about our approach The TeamMeet the ELAROS team CareersJoin us as we grow Contact Us If you’re interested in working with us, want to find out more, or have an idea for a collaboration, reach out! Email us: hello@elaros.com Follow us: Linkedin Instagram Facebook Youtube X-twitter Contact page
- [C19-YRS B2B Brochures](https://www.elaros.com/c19-yrs-b2b-brochures/) - C19-YRS B2B Brochures Clinical Research
- [Fattori di rischio del tumore al seno](https://www.elaros.com/mammoscreen-resources-it/understanding-breast-cancer-it/breast-cancer-risk-factors-it/) - Il rischio di cancro al seno è influenzato da un insieme di fattori genetici, ormonali, ambientali e di stile di vita. La comprensione di questi fattori di rischio aiuta a identificare coloro che potrebbero beneficiare di screening mirati, strategie di prevenzione e interventi precoci. Sebbene alcuni fattori di rischio siano associati al tumore al seno,
- [Il tumore al seno e i suoi sintomi](https://www.elaros.com/mammoscreen-resources-it/understanding-breast-cancer-it/about-breast-cancer-and-its-symptoms-it/) - Il tumore al seno è una malattia in cui le cellule del seno crescono in modo incontrollato. Ciò può avvenire sia nelle donne che negli uomini, anche se è più frequente nel sesso femminile. Questa crescita cellulare incontrollata può portare alla formazione di una massa o di un nodulo. Se non trattate, le cellule tumorali
- [Il Prevention Cluster](https://www.elaros.com/mammoscreen-resources-it/about-the-mammoscreen-project-it/prevention-cluster-it/) - Nel quadro della Mission Cancer dell’Unione Europea (EU Cancer Mission) (link di riferimento), i progetti finanziati che operano in aree di ricerca comuni collaborano all’interno dei cosiddetti Cluster di progetti.MammoScreen fa parte del Cluster “Prevention and Early Detection (Screening)”, dedicato alla prevenzione e alla diagnosi precoce di diversi tipi di tumori.Le attività del Cluster comprendono
- [Preparazione per un appuntamento MammoWave durante la sperimentazione](https://www.elaros.com/mammoscreen-resources-it/about-the-mammowave-process-it/preparing-for-a-mammowave-examination-during-the-trial-it/) - Una volta che la partecipante è stata arruolato per partecipare allo studio clinico e soddisfa i criteri di inclusione/esclusione, le verrà chiesto di firmare il consenso informato. Poiché la scansione MammoWave è un test non invasivo con una tecnologia a radiofrequenza a bassa potenza, non ci sono prerequisiti speciali che una partecipante deve fare prima del
- [Cancro al seno ereditario](https://www.elaros.com/mammoscreen-resources-it/understanding-breast-cancer-it/hereditary-breast-cancer-it/) - Il tumore ereditario al seno si verifica quando una persona eredita da uno o entrambi i genitori una mutazione genetica, da uno o entrambi i genitori, che aumenta il rischio di sviluppare il cancro al seno. I geni più comunemente noti legati al tumore al seno ereditario sono BRCA1 e BRCA2, ma anche altri possono
- [Il Progetto](https://www.elaros.com/mammoscreen-resources-it/about-the-mammoscreen-project-it/project-summary-it/) - Contesto della diagnosi del tumore al senoIl tumore al seno è il tipo di cancro più comune tra le donne a livello mondiale, con un’incidenza stimata di 1 donna su 8.L’Organizzazione Mondiale della Sanità (OMS) stima che nel 2022 i casi di tumore al seno abbiano rappresentato il 23,8% di tutti i tumori femminili, con
- [I partner di progetto](https://www.elaros.com/mammoscreen-resources-it/about-the-mammowave-process-it/project-partners-it/) - Efficienza e multidisciplinarietà rappresentano le fondamenta del progetto MammoScreen Per assicurare il raggiungimento di tutti gli obiettivi previsti dal progetto, è stata istituita una governance composta da partner con diverse expertise. Gli organi principali del progetto comprendono includino: Assemblea Generale (General Assembly)Comitato Etico e per la Gestione dei Dati (Data and Ethics Advisory Board)Comitato Scientifico
- [O Agrupamento de Prevenção](https://www.elaros.com/mammoscreen-resources-pt/about-the-mammoscreen-project-pt/prevention-cluster-pt/) - A Comissão Europeia associa projetos financiados com áreas de investigação em comum nos chamados Agrupamentos de projetos. O Projeto MammoScreen faz parte do Agrupamento de “Prevenção e deteção precoce (rastreio)” (também designado de Agrupamento de Prevenção), centrado na prevenção e deteção precoce de diferentes tipos de tumores.O trabalho do Agrupamento de Prevenção envolve várias iniciativas
- [Resumo do projeto](https://www.elaros.com/mammoscreen-resources-pt/about-the-mammoscreen-project-pt/project-summary-pt/) - Resumo de projeto Diagnóstico do cancro da mama – uma introdução: O cancro da mama é o cancro mais comum nas mulheres, afetando 1 em cada 8 mulheres em todo o mundo. A Organização Mundial de Saúde estima que, em 2020, o cancro da mama seja responsável por 24% de todos os casos de cancro
- [Socios del proyecto](https://www.elaros.com/mammoscreen-resources-es/about-the-mammoscreen-project-es/project-partners-es/) - Eficiencia y multidisciplinariedad: los pilares del proyecto MammoScreen: El proyecto MammoScreen cuenta con siete socios internacionales de Italia, Portugal, España y el Reino Unido, y dispone de una estructura de gobernanza multidisciplinar. Esta estructura prioriza una gestión eficiente y permite la realización exitosa de todas las tareas requeridas. Los principales órganos del proyecto son: Asamblea
- [Cáncer de mama hereditario](https://www.elaros.com/mammoscreen-resources-es/understanding-breast-cancer-es/hereditary-breast-cancer-es/) - Introducción al cuestionario de evaluación del riesgo de cáncer hereditario El cáncer de mama hereditario ocurre cuando una persona hereda una mutación genética de uno o ambos progenitores que aumenta su riesgo de desarrollar cáncer de mama. Los genes más comúnmente asociados con el cáncer de mama hereditario son BRCA1 y BRCA2, aunque existen otros
- [Guía paso a paso](https://www.elaros.com/mammoscreen-self-assess-es/step-by-step-tutorial-es/) - Resumen Existen diferentes formas de revisar el seno para detectar cáncer de mama: Autoexploración mamaria: Este método está ampliamente recomendado, pero es más útil si se realiza de manera regular y correcta. La autoexploración no debe reemplazar las mamografías ni los controles médicos realizados por un profesional, pero es útil para conocer tu propio cuerpo.
- [Grupo de Prevención](https://www.elaros.com/mammoscreen-resources-es/about-the-mammoscreen-project-es/prevention-cluster-es/) - En el marco de la Misión Cáncer de la Unión Europea [Link], los proyectos financiados que trabajan en áreas de investigación comunes se agrupan en clústeres de proyectos. MammoScreen forma parte del clúster de proyectos “Prevención y detección temprana (Screening)”, centrado en la prevención y detección precoz de distintos tipos de tumores.Los trabajos del Clúster
- [Resumen del proyecto](https://www.elaros.com/mammoscreen-resources-es/about-the-mammoscreen-project-es/project-summary-es/) - Antecedentes en el diagnóstico de cáncer de mama: El cáncer de mama es el tipo de cáncer más común entre las mujeres en todo el mundo, afectando a 1 de cada 8 mujeres. La Organización Mundial de la Salud (OMS) estima que, en 2022, los casos de cáncer de mama representaron el 23.8% de todos
- [Diferentes opciones de cribado](https://www.elaros.com/mammoscreen-resources-es/understanding-breast-cancer-es/different-screening-options-es/) - El cribado del cáncer de mama es fundamental para la detección temprana y para mejorar los resultados en personas con riesgo. Existen diversos métodos de cribado, cada uno con sus ventajas y limitaciones. La elección del método adecuado es importante y puede depender de factores como la edad y el nivel de riesgo. Mamografía (Mamografía
- [¿Qué es la densidad mamaria?](https://www.elaros.com/mammoscreen-resources-es/understanding-breast-cancer-es/breast-density-es/) - La densidad mamaria se refiere a la cantidad de tejido glandular y conectivo en relación con el tejido adiposo en la mama. Varía de persona a persona y generalmente se determina mediante una mamografía. La densidad de la mama se clasifica en cuatro categorías principales: 1. Mamas grasas:Estas mamas contienen más grasa que tejido glandular,
- [Factores de riesgo del cáncer de mama](https://www.elaros.com/mammoscreen-resources-es/understanding-breast-cancer-es/breast-cancer-risk-factors-es/) - El riesgo de desarrollar cáncer de mama está influido por una combinación de factores genéticos, hormonales, ambientales y relacionados con el estilo de vida. Comprender estos factores ayuda a identificar a las personas que podrían beneficiarse de cribados específicos, estrategias de prevención y detección temprana.Si bien algunos factores de riesgo están fuera de nuestro control,
- [El cáncer de mama y sus síntomas](https://www.elaros.com/mammoscreen-resources-es/understanding-breast-cancer-es/about-breast-cancer-and-its-symptoms-es/) - El cáncer de mama es una enfermedad en las que las células del tejido mamario crecen de manera descontrolada. Puede presentarse tanto en hombres como en mujeres, aunque es mucho más común en estas últimas. Este crecimiento celular descontrolado puede provocar la formación de una masa o bulto. Si no se trata, las células cancerosas
- [Guia passo a passo](https://www.elaros.com/mammoscreen-self-assess-pt/step-by-step-tutorial-pt/) - Perspetiva geral Existem diferentes formas de detetar o cancro da mama: Autoexame da mama: Este método é amplamente recomendado e bastante útil se for feito regularmente e corretamente. O autoexame da mama não deve substituir a mamografia ou o exame médico, mas é bom que conheça o seu corpo. Ainda se desconhece se o autoexame
- [La guida step-by-step](https://www.elaros.com/mammoscreen-self-assess-it/step-by-step-it/) - Introduzione Esistono diversi modi per verificare la presenza di un tumore al seno: Autopalpazione: Questo metodo è ampiamente raccomandato, ma deve essere eseguito regolarmente e correttamente. L’autopalpazione non sostituisce le mammografie o i controlli medici, ma è utile per imparare a conoscere il proprio corpo. Visita senologica: La visita senologica è condotta da un operatore
- [Step-by-Step Tutorial](https://www.elaros.com/mammoscreen-self-assess/step-by-step-tutorial/) - Overview There are different ways to check for breast cancer: Breast Self-Examination (BSE): This method is widely recommended, but it’s most useful if done regularly and correctly. BSE should not replace mammograms or check-ups by a doctor, but it’s helpful to know your body. Whether BSE can improve the early identification of a tumour by
- [Sobre a MammoWave](https://www.elaros.com/mammoscreen-resources-pt/about-the-mammowave-process-pt/about-mammowave-pt/) - MammoWave é uma tecnologia de imagiologia mamária não invasiva que utiliza sinais de micro-ondas inóquos, não ionisantes. Esta tecnologia inovadora não implica qualquer compressão na mama, assegurando um exame mamário exato e confortável independentemente da idade da mulher. Uma vez que pode ser realizado um número ilimitado de vezes e em qualquer condição de saúde,
- [Diferentes opções de rastreio de cancro da mama](https://www.elaros.com/mammoscreen-resources-pt/understanding-breast-cancer-pt/different-screening-options-pt/) - O rastreio do cancro da mama é fundamental para a sua deteção precoce e aumento da taxa de sucesso no tratamento de pessoas em risco. Há vários métodos de rastreio de cancro da mama disponíveis, cada um com os seus benefícios e limitações. A escolha do método correto é importante e depende de fatores como
- [O que é a densidade mamária?](https://www.elaros.com/mammoscreen-resources-pt/understanding-breast-cancer-pt/breast-density-pt/) - A densidade do tecido mamário depende da quantidade relativa de tecido glandular e conjuntivo em comparação com o tecido adiposo. A relação entre estes tipos de tecido mamário varia de pessoa para pessoa e geralmente é determinada com o auxílio de uma mamografia. A densidade da mama é classificada em quatro categorias principais: 1. Mama
- [Cancro da mama hereditário](https://www.elaros.com/mammoscreen-resources-pt/understanding-breast-cancer-pt/hereditary-breast-cancer-pt/) - O cancro da mama hereditário ocorre quando uma pessoa herda uma mutação genética de um ou de ambos os pais que aumenta o risco de desenvolver cancro da mama. Os genes mais conhecidos relacionados com o cancro da mama hereditário são o BRCA1 e o BRCA2, mas existem outros que também podem aumentar o risco.
- [Fatores de risco de cancro da mama](https://www.elaros.com/mammoscreen-resources-pt/understanding-breast-cancer-pt/breast-cancer-risk-factors-pt/) - O risco de cancro da mama é influenciado por uma mistura de fatores genéticos, hormonais, ambientais e de estilo de vida. A compreensão destes fatores de risco ajuda a identificar as pessoas que podem beneficiar de rastreios específicos, estratégias de prevenção e intervenção precoce. Embora alguns fatores de risco estejam associados ao cancro da mama,
- [Cancro da mama e seus sintomas](https://www.elaros.com/mammoscreen-resources-pt/understanding-breast-cancer-pt/aboyt-breast-cancer-and-its-symptoms-pt/) - O cancro da mama é uma doença em que as células do tecido mamário crescem de forma descontrolada. Pode ocorrer tanto em homens como em mulheres, mas é muito mais frequente nas mulheres. Este crescimento descontrolado das células pode levar à formação de uma massa ou nódulo. Se não forem tratadas, as células cancerígenas podem
- [Le diverse opzioni di screening options](https://www.elaros.com/mammoscreen-resources-it/understanding-breast-cancer-it/different-screening-options-it/) - Lo screening del cancro al seno è fondamentale per la diagnosi precoce e per migliorare gli esiti per le persone a rischio. Sono disponibili diversi metodi di screening, ciascuno con benefici e limiti. La scelta del metodo giusto è importante e può dipendere da fattori come l’età e il rischio. 1. Mammografia (Mammografia digitale 2D
- [Acerca de MammoWave](https://www.elaros.com/mammoscreen-resources-es/about-the-mammowave-process-es/about-mammowave-es/) - Acerca de MammoWave MammoWave es una tecnología que utiliza señales de microondas seguras, no invasivas y no ionizantes para obtener imágenes de la mama. No aplica ninguna compresión a la mama y esta novedosa tecnología también se puede utilizar para examinar a las mujeres jóvenes. Podría garantizar un examen de mama preciso y cómodo para
- [Che cos'è la densità del seno?](https://www.elaros.com/mammoscreen-resources-it/understanding-breast-cancer-it/breast-density-it/) - La densità mammaria si riferisce alla quantità di tessuto ghiandolare e connettivo rispetto al tessuto adiposo nel seno. Varia da persona a persona e viene solitamente determinata attraverso una mammografia. La densità del seno è classificata in quattro categorie principali: 1.Seni grassi:Questi seni hanno più grasso che tessuto ghiandolare, il che rende più facile individuare
- [I risultati di MammoWave](https://www.elaros.com/mammoscreen-resources-it/about-the-mammowave-process-it/about-mammowave-it/about-the-mammowave-results-it/) - I risultati di MammoWave saranno inviati allo specialista coinvolto nell’esame MammoWave e saranno composti da immagini a microonde, più etichette che saranno ottenute utilizzando un algoritmo di classificazione ottimizzato. Tale algoritmo è stato sviluppato utilizzando i dati clinici raccolti in un precedente studio internazionale e multicentrico, utilizzando approcci di AI (come macchine vettoriali di supporto,
- [Informazioni sul processo MammoWave durante la sperimentazione](https://www.elaros.com/mammoscreen-resources-it/about-the-mammowave-process-it/about-the-mammowave-process-during-the-trial-it/) - I volontari interessati a partecipare allo studio clinico MammoScreen devono essere consapevoli che questo studio clinico è condotto nell’ambito di un progetto europeo (MammoScreen), volto a fornire una convalida della tecnologia MammoWave per lo screening mammografico. Pertanto, i risultati di MammoWave saranno confrontati con quelli di un esame del seno convenzionale. Una volta che una
- [Informazioni su MammoWave](https://www.elaros.com/mammoscreen-resources-it/about-the-mammowave-process-it/about-mammowave-it/) - MammoWave è una tecnologia per l’imaging del seno che utilizza segnali a microonde sicuri, non invasivi e non ionizzanti. Non applica alcuna compressione al seno e questa nuova tecnologia può essere utilizzata per esaminare anche le donne giovani. Potrebbe garantire un esame del seno accurato e confortevole per le donne di tutte le età, oltre
- [Acerca del proceso de MammoWave durante el ensayo](https://www.elaros.com/mammoscreen-resources-es/about-the-mammowave-process-es/about-the-mammowave-process-during-the-trial-es/) - Las voluntarias interesadas en participar en el ensayo clínico MammoScreen deben saber que este estudio clínico se lleva a cabo en el marco de un proyecto europeo (MammoScreen), destinado a proporcionar validación de la tecnología MammoWave para el cribado del cáncer de mama. Por lo tanto, los resultados de MammoWave se compararán con los resultados
- [Preparación para una cita con MammoWave durante el ensayo](https://www.elaros.com/mammoscreen-resources-es/about-the-mammowave-process-es/preparing-for-a-mammowave-examination-during-the-trial-es/) - Una vez que una participante haya sido aceptada para participar en el ensayo clínico y cumpla con los criterios de inclusión/exclusión, se le pedirá que firme el consentimiento informado.Debido a que el escaneo con MammoWave es una prueba no invasiva con una tecnología de radiofrecuencia de baja potencia, no hay requisitos previos especiales que un
- [Informazioni sul MammoScreen Project](https://www.elaros.com/mammoscreen-resources-it/about-the-mammoscreen-project-it/) - Scopri di più sul progetto e sui diversi membri coinvolti
- [Informazioni sul processo MammoWave](https://www.elaros.com/mammoscreen-resources-it/about-the-mammowave-process-it/) - Questa sezione spiegherà come prepararsi e cosa aspettarsi da un esame con MammoWave, quando sarà disponibile
- [Capire il cancro al seno](https://www.elaros.com/mammoscreen-resources-it/understanding-breast-cancer-it/) - Dai un’occhiata a queste risorse per saperne di più sul cancro al seno, fattori di rischio e sulle opzioni di screening
- [Acerca del proyecto MammoScreen](https://www.elaros.com/mammoscreen-resources-es/about-the-mammoscreen-project-es/) - Conoce más sobre el proyecto y los diferentes socios involucrados.
- [Sobre os resultados do exame MammoWave](https://www.elaros.com/mammoscreen-resources-pt/about-the-mammowave-process-pt/about-the-mammowave-results-pt/) - Os resultados do exame MammoWave serão enviados para o especialista responsável pelo exame e serão compostos por sinais de micro-ondas e a categorização obtida através de um algoritmo de classificação optimizado. Este algoritmo foi desenvolvido com base nos dados clínicos recolhidos num estudo anterior, internacional e multicêntrico, que utilizou abordagens de inteligência artificial (incluindo modelos
- [Sobre o processo MammoWave durante o ensaio clínico](https://www.elaros.com/mammoscreen-resources-pt/about-the-mammowave-process-pt/about-the-mammowave-process-during-the-trial-pt/) - Os voluntários interessados em participar no ensaio clínico do Projeto MammoScreen devem estar cientes de que este estudo clínico é realizado no âmbito de um projeto financiado pelo União Europeia, destinado a validar a tecnologia MammoWave em rastreio mamário. Os resultados obtidos com o exame MammoWave serão comparados com os resultados de um exame mamário
- [Preparação para uma consulta MammoWave durante o ensaio clínico](https://www.elaros.com/mammoscreen-resources-pt/about-the-mammowave-process-pt/preparing-for-a-mammowave-examination-during-the-trial-pt/) - Para que uma voluntária seja aceite para participar no ensaio clínico, esta deverá preencher os critérios de inclusão e, na ausência de fatores de exclusão, ser-lhe-á pedido que assine um consentimento informado.Sendo o MammoWave um exame não invasivo e que utiliza uma tecnologia de radiofrequência de baixa potência, não existem pré-requisitos especiais que as participantes
- [Sobre el proceso de MammoWave](https://www.elaros.com/mammoscreen-resources-es/about-the-mammowave-process-es/) - En esta sección, repasaremos cómo prepararte y qué esperar en una cita de MammoWave, cuando esté disponible.
- [Entendiendo el cáncer de mama](https://www.elaros.com/mammoscreen-resources-es/understanding-breast-cancer-es/) - Consulta estos recursos para obtener más información sobre el cáncer de mama, sus factores de riesgo y tus opciones de detección.
- [Sobre o Projeto MammoScreen](https://www.elaros.com/mammoscreen-resources-pt/about-the-mammoscreen-project-pt/) - Saiba mais sobre o projeto e os diferentes parceiros nele envolvidos
- [Sobre o Processo MammoWave](https://www.elaros.com/mammoscreen-resources-pt/about-the-mammowave-process-pt/) - Esta secção explicará como se pode preparar e o que pode esperar numa consulta MammoWave, quando esta estiver disponível
- [Compreender o cancro de mama](https://www.elaros.com/mammoscreen-resources-pt/understanding-breast-cancer-pt/) - Consulte estes recursos para saber mais sobre o cancro da mama e seus fatores de risco, bem como opções de rastreio
- [Acerca de los resultados de MammoWave](https://www.elaros.com/mammoscreen-resources-es/about-the-mammowave-process-es/about-the-mammowave-results-es/) - Los resultados de MammoWave se enviarán al especialista implicado en el examen de MammoWave y se compondrán de imágenes de microondas, además de etiquetas que se obtendrán mediante un algoritmo de clasificación optimizado. Dicho algoritmo se ha desarrollado utilizando los datos clínicos recopilados en un estudio internacional multicéntrico previo, utilizando enfoques de IA (como máquinas
- [Recursos educativos de MammoScreen](https://www.elaros.com/mammoscreen-resources-es/)
- [Autoevaluación de las mama](https://www.elaros.com/mammoscreen-self-assess-es/)
- [About the MammoWave results](https://www.elaros.com/mammoscreen-resources/about-the-mammowave-process/about-the-mammowave-results/) - MammoWave results will be sent to the specialist involved in the MammoWave examination and will be composed of microwave images, plus labels which will be obtained using an optimised classification algorithm. Such algorithm has been developed using the clinical data collected in a previous international, multicentric study, using AI approaches (such as support vector machines,
- [Preparing for a MammoWave appointment during the trial](https://www.elaros.com/mammoscreen-resources/about-the-mammowave-process/preparing-for-a-mammowave-examination-during-the-trial/) - Once a participant has been accepted to participate in the clinical trial and she fulfils inclusion/exclusion criteria, she will be asked to sign the informed consent.Due to the MammoWave scan being a non-invasive test with a low-power radiofrequency technology, there are no special prerequisites that a participant needs to do before the test (e.g. participant
- [About the MammoWave process during the trial](https://www.elaros.com/mammoscreen-resources/about-the-mammowave-process/about-the-mammowave-process-during-the-trial/) - Volunteers interested in participating in MammoScreen clinical trial should be aware that this clinical study is conducted within the framework of a European Project (MammoScreen), aimed at providing validation of the MammoWave technology for breast screening. Thus, MammoWave results will be compared versus the output of conventional breast examination path. Once a participant has been
- [About MammoWave](https://www.elaros.com/mammoscreen-resources/about-the-mammowave-process/about-mammowave/) - MammoWave is a technology that uses safe, non-invasive, and non-ionizing microwave signals for breast imaging purposes. It does not apply any compression to the breast and the novel technology can be used to screen young women as well. It could ensure accurate and comfortable breast examination for woman of all ages, as well as being
- [Different screening options](https://www.elaros.com/mammoscreen-resources/understanding-breast-cancer/different-screening-options/) - Breast cancer screening is key for early detection and improving outcomes for people at risk. Several screening methods are available, each with benefits and limitations. Choosing the right method is important and can depend on factors like age and risk. 1. Mammography (Full Field 2D Digital Mammography or 3D Digital Breast Tomosynthesis) What It Is:
- [Breast Cancer Risk Factors](https://www.elaros.com/mammoscreen-resources/understanding-breast-cancer/breast-cancer-risk-factors/) - Breast cancer risk is influenced by a mix of genetic, hormonal, environmental, and lifestyle factors. Understanding these risk factors helps identify people who might benefit from targeted screenings, prevention strategies, and early intervention. While some risk factors associated with breast cancer is crucial for individuals to be proactive about their health. While some risk factors
- [About breast cancer and it's symptoms](https://www.elaros.com/mammoscreen-resources/understanding-breast-cancer/about-breast-cancer-and-its-symptoms/) - Breast cancer is a disease where cells in the breast grow uncontrollably. It can occur in both men and women, but it is far more common in women. This uncontrolled cell growth can lead to the formation of a mass or lump. If left untreated, breast cancer cells can spread to other parts of the
- [Project Summary](https://www.elaros.com/mammoscreen-resources/about-the-mammoscreen-project/project-summary/) - Breast Cancer Diagnosis Background Breast cancer is the most common cancer in women worldwide, affecting 1 in 8 women. The World Health Organisation estimates that in 2020, worldwide cases of breast cancer accounted for 24% of all cancers in women, with 2.26 million women diagnosed with cancer and 685,000 deaths globally. MammoScreen and the wider
- [Risorse Mammoscreen](https://www.elaros.com/mammoscreen-resources-it/)
- [Autopalpazione](https://www.elaros.com/mammoscreen-self-assess-it/)
- [Parceiros do projeto](https://www.elaros.com/mammoscreen-resources-pt/about-the-mammoscreen-project-pt/project-partners-pt/) - Eficiência e multidisciplinaridade: os pilares do projeto MammoScreen De modo a garantir que todas as tarefas sejam concluídas com êxito, foi criada a seguinte estrutura de governação multidisciplinar: Os principais órgãos governativos do projeto incluem: Assembleia GeralConselho Consultivo para a Ética e Proteção de DadosConselho Científico ConsultivoGrupo Consultivo de PacientesConselho de Gestão de Conhecimento Assembleia
- [MammoScreen Autoexame das mamas](https://www.elaros.com/mammoscreen-self-assess-pt/)
- [Recursos do MammoScreen](https://www.elaros.com/mammoscreen-resources-pt/)
- [MammoScreen Resources](https://www.elaros.com/mammoscreen-resources/)
- [Prevention Cluster](https://www.elaros.com/mammoscreen-resources/about-the-mammoscreen-project/prevention-cluster/) - Under the European Commission, funded projects that work on common research areas are teaming up in the Cluster of projects. MammoScreen is part of the ‘Prevention and early detection (Screening)’ cluster of projects, centred on the prevention and early detection of different types of tumours. The Cluster’s work will involve different joint activities, including a common
- [Project Partners](https://www.elaros.com/mammoscreen-resources/about-the-mammoscreen-project/project-partners/) - Efficiency and multidisciplinary: The foundations of the MammoScreen project A multidisciplinary governance structure has been created to make sure that all the tasks are successfully completed: The main bodies of the project include: General Assembly Data and Ethics Advisory Board Scientific Advisory Board Patient Advisory Group and Knowledge Management Board General Assembly The General Assembly is composed of
- [Breast density](https://www.elaros.com/mammoscreen-resources/understanding-breast-cancer/breast-density/) - Breast density refers to the amount of glandular and connective tissue compared to fatty tissue in the breasts. It varies from person to person and is usually determined through a mammogram. Breast density is classified into four main categories: 1. Fatty Breasts:These breasts have more fat than glandular tissue, making it easier to spot any
- [Hereditary breast cancer](https://www.elaros.com/mammoscreen-resources/understanding-breast-cancer/hereditary-breast-cancer/) - Hereditary breast cancer occurs when a person inherits a ​​gene mutation from one or both parents that raises their risk of developing breast cancer. The most commonly known genes related to hereditary breast cancer are BRCA1 and BRCA2, but other can also increase risk. Here’s a quick overview of some important genes associated with hereditary
- [About the MammoScreen Project](https://www.elaros.com/mammoscreen-resources/about-the-mammoscreen-project/) - Learn more about the project and the different partners involved
- [Understanding Breast Cancer](https://www.elaros.com/mammoscreen-resources/understanding-breast-cancer/) - Check out these resources to learn more about breast cancer, its risk factors and your screening options
- [About the MammoWave Process](https://www.elaros.com/mammoscreen-resources/about-the-mammowave-process/) - This section will run through how to prepare for and what to expect at a MammoWave appointment, when it is available
- [MammoScreen Self-Assess](https://www.elaros.com/mammoscreen-self-assess/)
- [MammoScreen App Privacy Policy](https://www.elaros.com/mammoscreen-app-privacy-policy/) - MammoScreen App Privacy Policy Privacy Policy for MammoScreen Lite Mobile App Thank you for choosing the MammoScreen app, a mobile application dedicated to providing information about the EU funded-MammoScreen project (referred to as the project) and the groundbreaking breast screening technology, MammoWave. This Privacy Policy outlines our approach to handling your information while you use our
- [CQI Toolkit](https://www.elaros.com/solutions/cqi-toolkit/) - Empowering Users to Develop and Sustain Continuous Quality Improvement Project Management Project JustificationBenefit RealisationsAction LogStakeholder AnalysisIssues LogProject TimelinePESTLE AnalysisContinuous Monitoring CQI Tools Takt TimeCapacity CalculatorWaste WalkValue Stream MapCost TimeTransportWorkforce Reconfiguration Quality Outputs Statistical AnalysisReturn On InvestmentReport TemplateHypothesis Staff Indicators Staff Health and WellbeingStaff Feedback About The CQI Toolkit™ was designed in-house by experts at NHS
- [User Preference study](https://www.elaros.com/solutions/neu-restore/user-preference-study/) - Neu-RestoreUser Preference Study Are you a stroke survivor, carer or a healthcare professional in stroke? Your opinion would be very valuable to us! As part of ELAROS’s Innovate UK funded project, Neu-Restore, we are running a user preference study to provide input into its design. Neu-Restore will be a digital stroke management platform which aims to improve the
- [Testimonials](https://www.elaros.com/customers-2/) - Testimonials Abi CampbellClinical Service Lead "Lanarkshire have been so impressed with the capacity and capability the digital C19-YRS system brings to our Long Covid Rehabilitation Pathway. Since adoption, people with Long Covid have their initial screening three weeks faster, on average, meaning they are triaged and added to the waiting list 3 weeks sooner. Administration
- [Customers](https://www.elaros.com/customers/) - Customers Proud to collaborate and innovate with customers in the NHS and around the world

## Dynific Global Templates

- [Toby bio popup](https://www.elaros.com/?ae_global_templates=toby-bio-popup) - Toby BoudResearch and Development Manager Toby is a graduate of The University of Sheffield, with an MEng in Biomaterials Science and Engineering. This is an interdisciplinary degree studying materials for use inside the body, it draws aspects from materials science and bioengineering; covering topics such as materials processing, cell and molecular biology, physics of living
- [Chris Russell bio popup](https://www.elaros.com/?ae_global_templates=chris-russell-bio-popup) - Dr Christopher Russell CTO and co-founder of Vivisco Limited Chris is the CTO of Innovate UK funded Vivisco Limited where he develops prototype healthcare technologies with an emphasis on affordability and usability. Chris has a BEng and PhD from School of Electronic and Electrical Engineering at the University of Leeds. He initially undertook a post-doctoral
- [Davide bio pop-up](https://www.elaros.com/?ae_global_templates=davide-bio-pop-up) - Davide RighiBusiness Development Associate Davide first joined ELAROS as a Digital Health Marketing Intern in August 2024 and has recently concluded his eleven-month industrial placement as a Business Development Associate where he was involved in commercialisation through lead generation, outreach, and website re-design working alongside colleagues on the autonom-e and NROL platforms.He is currently studying
- [Steve bio pop-up](https://www.elaros.com/?ae_global_templates=steve-bio-pop-up) - Steve RobsonClinical Safety Officer Steve Robson is an experienced Clinical Safety Officer and registered nurse with over 14 years’ experience working across the NHS, spanning frontline clinical practice, digital transformation, and clinical safety assurance.Steve worked as a registered nurse before moving into Clinical Informatics, where he played a key role in the delivery of major
- [Manoj bio popup](https://www.elaros.com/?ae_global_templates=paul-bio-popup-2) - Prof. Manoj SivanWHO, University of Leeds and Leeds NHS Trusts Prof Manoj Sivan is the Clinical Research Lead for the NRC. He is a full Professor and a Consultant in Physical and Rehabilitation Medicine (PRM) in Leeds, and the current Research and Clinical Standards Chair of the British Society of PRM.Prof Sivan is in the
- [Scarlett bio pop-up](https://www.elaros.com/?ae_global_templates=celia-bio-pop-up) - Scarlett ShawSoftware Quality Assurance Lead Scarlett graduated with a First Class Honours BSc in Computer Science with Artificial Intelligence from Sheffield Hallam University. Her academic journey encompassed modules in AI and Machine Learning, Advanced Programming, and Algorithms and Data Structures, reflecting her deep-seated passion for technology and problem-solving.Scarlett’s initial engagement with ELAROS occurred during the
- [Giacomo bio pop-up](https://www.elaros.com/?ae_global_templates=giacomo-bio-pop-up) - Giacomo SpotiWearables Integration Project Intern Giacomo is a master’s student in Management Engineering at the University of Florence. During his studies he built skills in industrial engineering, business management, process management, and IT with a focus on operations, project management, and digital innovation.Curious about working internationally and keen to gain experience abroad, he looked for
- [Paul bio pop-up](https://www.elaros.com/?ae_global_templates=paul-bio-popup) - Prof. Paul O’BrienChief Executive Officer and Director Professor Paul O’ Brien was appointed CEO of ELAROS 24/7 in April 2012. Paul has held senior posts in the private sector (Chief Executive), local government (Chief Officer), health (Director in West Essex NHS Trust) and education (Head of Department).He has previous venture start-up experience having established the
- [Owain bio pop-up](https://www.elaros.com/?ae_global_templates=owain-bio-popup) - Owain MedfordPhD Researcher Owain is currently a PhD student in Electronic and Electrical Engineering at the University of Huddersfield after graduating with a First Class BEng (Hons) in Electronic and Electrical Engineering.In addition to general engineering principles and the generation and manipulation of electrical power, his undergraduate degree also covered the implementation of electronics, computer
- [Bárbara bio pop-up](https://www.elaros.com/?ae_global_templates=barbara-bio-popup) - Bárbara Silva PassadouroPhD Researcher Bárbara is a MRC DiMeN funded PhD student at the University of Leeds interested in the neurophysiology of chronic pain in Long COVID. She graduated with a First-Class Honours BSc Neuroscience with Industrial Experience degree from the University of Manchester.As part of her final year academic research project, she joined the
- [Tom bio pop-up](https://www.elaros.com/?ae_global_templates=tom-bio-popup) - Dr Tom RichardsScientific Director of Neu-Restore Dr Thomas Richards joined Elaros in 2022 as Scientific Director of the Neu-Restore platform. He studied a BSc in Medical Science (2014) followed by a PhD in neurophysiology (2018) at the University of Leeds. During his doctoral studies, he worked both in research, studying motor control pathways, and in
- [Michalina bio pop-up](https://www.elaros.com/?ae_global_templates=iona-bio-pop-up) - Michalina GersSoftware Quality Assurance Intern Michalina is currently in her final year of a BSc in Computer Science with Artificial Intelligence at Sheffield Hallam University. Her degree spans a wide range of topics, including core computer science principles, databases, computer architecture, AI and machine learning, software and UI/UX design, and advanced programming.Throughout her studies, Michalina
- [Lakshitha bio pop-up](https://www.elaros.com/?ae_global_templates=lakshitha-bio-pop-up) - Lakshitha KumaranayakalageSoftware Developer Lakshitha is a dedicated and skilled software developer with over six years of experience in the IT/SE sector. He is a graduate from the University of Salford with a Master’s degree in Data Science, which complements his extensive hands-on experience across various domains of software development. His career includes a notable role as a
- [James bio pop-up](https://www.elaros.com/?ae_global_templates=james-mcmunn-bio-pop-up) - James McMunnSenior Software Developer James has worked for 20+ years around a broad set of technologies and across a wide range of sectors, including; Health, Insurance, Finance, and Travel (The British Library, Jet2 and Confused.com).James has worked on complex software projects, from building databases, assessing security risks, streamlining backend code to building cloud infrastructure.Over the
- [Blesson bio pop-up](https://www.elaros.com/?ae_global_templates=blesson-bio-pop-up) - Blesson Ezra Research and Development Manager Blesson is a MEng Bioengineering graduate at the University of Sheffield, specialising in Tissue Engineering and Biomaterials, who will be joining ELAROS full time in September 2024.He has a keen interest in the future of digital healthcare, biomimetics and biomaterials. He’s particularly driven in the natural materials aspect of his
- [Dan bio pop-up](https://www.elaros.com/?ae_global_templates=daniel-bio-popup) - Daniel Weatherill Management Accountant Dan is a recent graduate from The University of Sheffield, studying Business Management.He particularly enjoyed the maths and data side of his course, exploring how software can assist with decision making. He also found a particular interest in the responsible business side of the course, such as Corporate Social Responsibility and Corporate
- [Claire bio pop-up](https://www.elaros.com/?ae_global_templates=claire-horton-bio) - Dr Claire HortonStrategic Communications Director Dr Claire Horton first joined Elaros in November 2017 as the Project Manager of the iCARHO project (Managing Health and Wellbeing in Care Homes with Digital Solutions) which resulted in an early version of Elaros’ product, The Care Home Guide to Dysphagia. She rejoined Elaros in June 2025 as the
- [Román bio pop-up](https://www.elaros.com/?ae_global_templates=roman-bio-popup) - Román Rocha LawrenceCommercialisation Director Román Rocha Lawrence joined ELAROS in July 2019 as our Graduate Research & Development Manager after graduating from The University of Sheffield with a First Class Honours MEng Degree in Bioengineering. As part of his degree which drew on various engineering disciplines, management, science and medicine, Román specialised in Biomaterials, Tissue
- [Peter bio pop-up](https://www.elaros.com/?ae_global_templates=peter-bio-popup) - Peter CunliffeFinance Director Peter Cunliffe qualified as a Chartered Accountant in 1983, having trained in Birmingham with one of the then ‘Big 4’ accountancy firms, Deloitte Haskins and Sells.Since qualifying, Peter has worked in various finance and accounting roles for a wide spectrum of businesses, both in terms of size (£3m up to £1.2bn turnover)
- [Izaak bio pop-up](https://www.elaros.com/?ae_global_templates=abdul-bio-pop-up) - Izaak WalkerProduct Development Manager Izaak Walker initially joined ELAROS on a part-time basis in January 2025 while wrapping up his integrated master’s degree at the University of Sheffield where his drive to address unmet clinical needs led to his industrial collaboration with Metallobio to support his master’s thesis where he developed photocurable, antimicrobial, drug-eluting material
- [C19-YRS Partners](https://www.elaros.com/?ae_global_templates=c19-yrs-partners) - C19-YRS Partners Proud to collaborate and innovate with customers in the NHS and around the world
- [C19-YRS About the PROM](https://www.elaros.com/?ae_global_templates=about-the-prom) - About the PROM The C19-YRS is the world’s first clinically validated, condition-specific screening tool, used to assess the severity of common persistent symptoms identified in patients after contracting COVID-19, a condition known as “Long COVID” or “post-COVID-19 syndrome”. The self-reporting tool has been developed by clinical academics at The University of Leeds and has been
- [C19-YRS About the System](https://www.elaros.com/?ae_global_templates=c19-yrs-about-the-system) - About the system ELAROS’ C19-YRS was rapidly developed to a high standard, by working closely with clinical researchers at University of Leeds and Pipe & Piper Ltd to pivot ELAROS’ existing CE-marked Digital Bladder Diary platform. The paper C19-YRS self-report is being slowly adopted by NHS Trusts across the UK as of December 2020. ELAROS’
- [C19-YRS Testimonials](https://www.elaros.com/?ae_global_templates=grad-rd-associate-2) - C19-YRS Testimonials Abi CampbellClinical Service LeadNHS Lanarkshire Health Board“Lanarkshire have been so impressed with the capacity and capability the digital C19-YRS system brings to our Long Covid Rehabilitation Pathway. Since adoption, people with Long Covid have their initial screening three weeks faster, on average, meaning they are triaged and added to the waiting list 3
- [Elaros Outstanding Collaborators](https://www.elaros.com/?ae_global_templates=elaros-providers) - Outstanding Collaborators We are supported and recognised by renowned organisations throughout the UK and internationally
- [Elaros Trusted Partners](https://www.elaros.com/?ae_global_templates=elaros-collaborators) - Trusted Partners We are proud to work with over 70 healthcare organisations and Universities
- [Arianna Conti Bio](https://www.elaros.com/?ae_global_templates=arianna-conti-bio) - Arianna ContiROVER Project Intern Arianna is an Italian student at the University of Florence, pursuing a Master’s degree in Management Engineering.During her bachelor’s degree in Management Engineering, she had the opportunity to develop specific skills in industrial engineering, combining design, economics, business management, and information technology. Having chosen the Computer-Industrial path, she was also exposed
- [Lydia Tobi Bio](https://www.elaros.com/?ae_global_templates=lydia-tobi-bio) - Lydia Tobi Digital Marketing Intern Lydia is in her final year of a BA in Business Management at the University of Sheffield, where her degree explores a broad mix of subjects including marketing, human resources, corporate social responsibility, business analytics, and financial management.Her main interests centre around digital marketing, events, and social media content creation. Over
- [Louise Connell Bio](https://www.elaros.com/?ae_global_templates=louise-connell-bio) - Professor Louise Connell Professor of Allied Health Rehabilitation | Lancaster University | East Lancashire Hospitals NHS Trust Louise Connell is Professor of Allied Health Rehabilitation. She works as a clinical- academic in a partnership post between Lancaster University and East Lancashire Hospitals NHS Trust. Louise integrates implementation science into rehabilitation, demonstrating how its theories, models and
- [ROVER](https://www.elaros.com/?ae_global_templates=rover) - ROVER RISE Project: Reliable Technologies and Models for Verified Wireless Body-centric Transmission and Localisation Global variations in healthcare funding, a growing, ageing demographic, explosions in the availability of health and digital data and new digital technologies are all converging to transform healthcare.ROVER unites a highly skilled and motivated multidisciplinary team of developing researchers, innovators and
- [NIHR Locomotion](https://www.elaros.com/?ae_global_templates=nihr-locomotion) - LOCOMOTION: LOng COvid Multidisciplinary consortium: Optimising Treatments and servIces acrOss the NHS The Challenge Long COVID refers to a set of symptoms that persist for longer than four weeks after contracting coronavirus. Long COVID has many symptoms, including breathlessness, fatigue, and brain ‘fog’. It has the potential to deepen health inequalities and is having a
- [SBRI - NROL](https://www.elaros.com/?ae_global_templates=sbri-nrol) - NROL: Scaling and Evaluating NeuroRehabilitation OnLine (NROL) Model: Enhancing Access to Intensive Digital Stroke Rehabilitation Across NHS Regions for Better Outcomes The NROL SBRI project will support the expansion and evaluation of the NROL programme – a real-time digital stroke rehabilitation delivery model (created by UCL and SameYou in 2020) – at both local ICBs,
- [Design Foundations - Dysphagia Guide](https://www.elaros.com/?ae_global_templates=design-foundations-dysphagia-guide) - Dysphagia Guide – a guide to managing care home residents with swallowing difficulties Dysphagia, a condition that affects the ability to chew and swallow, poses serious health risks including malnutrition, dehydration, and choking. Despite its prevalence in care settings, there was a lack of accessible, standardised training to equip carers and healthcare staff with the
- [Innovate UK - Digital Bladder Diary](https://www.elaros.com/?ae_global_templates=sbri-adjustments-by-open-oh-copy) - The Digital Bladder Diary: Reducing unnecessary referrals to secondary care and empowering GPs to make clinical decisions closer to the patient Two-thirds of adults will experience bladder issues in their lifetime. Diagnosis typically involves a paper bladder diary, which is often inconvenient, error-prone, and delays treatment. This can lead to unnecessary referrals and pressure on
- [SBRI Adjustments by Open-OH](https://www.elaros.com/?ae_global_templates=sbri-adjustments-by-open-oh) - SBRI – Adjustments by Open-OH Many people living with long-term conditions like Fibromyalgia, Long Covid, ME/CFS, and POTS face serious challenges at work—especially when it comes to mental health and securing appropriate workplace adjustments. Conditions like anxiety, brain fog, and stigma often make it harder to stay in or return to employment.Adjustments by Open-OH is
- [SBRI - Open-OH Phase 2](https://www.elaros.com/?ae_global_templates=innovate-uk-open-oh-phase-2) - Open-OH: Increasing access to and capacity in Occupational Health: Phase 2 Open-OH Phase 2, supported by Innovate UK, Department for Work and Pensions (DWP), and Department of Health and Social Care (DHSC), builds on ELAROS’ existing occupational health platform to develop a smart digital solution that supports employees with Long Covid and other long-term conditions. Funded
- [Innovate UK - Neu-restore](https://www.elaros.com/?ae_global_templates=innovate-uk-neu-restore) - Neu-Restore: A new way of assessing post-stroke recovery Upper limb impairment is one of the most common long-term effects of stroke. Yet, stroke assessment and rehabilitation still rely heavily on subjective observations. Clinicians need more reliable and predictive tools to support decision-making, especially with growing caseloads and added pressures from Long Covid.Neu-Restore™ is a digital
- [SBRI - Open-OH Phase 1](https://www.elaros.com/?ae_global_templates=sbri-open-oh-phase-1) - Open-OH: Increasing access to and capacity in Occupational Health: Phase 1 Open-OH Phase 1, supported by Innovate UK, Department for Work and Pensions (DWP), and Department of Health and Social Care (DHSC), seeked out to develop a smart digital solution that supports employees with Long Covid and other long-term conditions. Funded through the SBRI Healthcare
- [SBRI Grant - Sleepy Fox](https://www.elaros.com/?ae_global_templates=sbri-grant-sleepy-fox) - The Digital Sleep Diary (Sleepy Fox): The self-management and remote monitoring app Sleep is vital for children’s development, yet many families struggle with common behavioural sleep issues—such as difficulties falling asleep, staying asleep, and early awakenings. These issues can lead to broader health and wellbeing challenges for both the child and their caregivers.Sleepy Fox™ is
- [Innovate UK - Mammowave](https://www.elaros.com/?ae_global_templates=innovate-uk-mammowave) - MammoScreen - Innovative and safe microwave based imaging technology to make breast cancer screening more accurate, inclusive, and female-friendly The ChallengeBreast cancer remains the most prevalent cancer among women globally. Traditional mammography, while effective, has limitations—particularly in women with dense breast tissue and younger demographics. These limitations can lead to missed diagnoses and reduced screening
- [Jennifer bio popup](https://www.elaros.com/?ae_global_templates=jennifer-bio-popup) - Jennifer McDonaldPPIE Manager and Project Manager of MammoScreen In March 2023, Jennifer began in her new role at ELAROS as MammoScreen Project Manager. Her primary responsibility will be delivering ELAROS’ role in the multinational MammoScreen project, which uses ultra-wideband (UWB) imaging methods for accurate, effective and safer screening of breast cancer.After graduating from the University
- [Angel Bio Pop Up](https://www.elaros.com/?ae_global_templates=angel-bio-pop-up) - Dr Angel Jimenez-ArandaAssociate Professor of Digital Transformation | University of Salford Angel has extensive experience in management and digital innovation across Higher Education, the NHS, and the private sector. From 2013 to 2021, Angel led healthcare technology initiatives at an NHS hospital, developing digital innovations that comply with medical regulations and support healthcare professionals. From
- [Jeremy Bio pop-up](https://www.elaros.com/?ae_global_templates=jeremy-bio-pop-up) - Jeremy GeeCommunity Advanced Practitioner | Airedale NHS Foundation Trust Jeremy qualified as a Physiotherapist in 2009 working rotationally across a wide variety of key areas within Airedale NHS Foundation Trust before focussing mainly on rehabilitation of older adults both in inpatient and community settings. After completing a Masters in Advanced Practice at the University of
- [Dean bio popup](https://www.elaros.com/?ae_global_templates=dean-bio-popup) - Dean MawsonClinical Director and Founder of DPM – Digital Health Dean Mawson has supported the Clinical Risk Management movement in the NHS working in collaboration with NHS Digital and prominent Clinical leaders within the digital health sector for over 18 years. Dean has contributed his clinical experience and knowledge base to NHS Clinical Safety &
- [Wendy bio popup](https://www.elaros.com/?ae_global_templates=wendy-bio-popup) - Wendy Watson MBEHereditary Breast Cancer Helpline Wendy Watson MBE was the first BRCA carrier in the UK to undergo a preventive double mastectomy after discovering that 9 of her female relatives had developed breast cancer, taking a novel elective surgery before a potential diagnosis arose.In 1996, she held the world’s first Hereditary Breast Cancer Awareness
- [Matt bio popup](https://www.elaros.com/?ae_global_templates=matt-bio-popup) - Matt AbramsDirector at Pipe and Piper Matt Abrams graduated from Sheffield Hallam University with a BSc (Hons) in Business Information Technology and later co-founded PNP Digital in 2012. Previously the Operations Director for a web design agency, Matt developed a range of skills and experience that finally led to him set up his own company
- [Software Quality Assurance Intern](https://www.elaros.com/?ae_global_templates=software-quality-assurance-intern) - Software Quality Assurance Intern Overview The Software Quality Assurance (SQA) Intern will report to the Regulatory Affairs Manager, and will be responsible for overseeing and evidencing the quality of ELAROS’s commercial and R&D product portfolio. This will involve aspects of risk management, quality assurance – defining management and testing strategies, and quality control – performing
- [Digital Marketing Intern](https://www.elaros.com/?ae_global_templates=digital-marketing-intern) - Digital Health Marketing Intern ELAROS is a UK-based digital health provider, incubator, and accelerator of solutions for the health, care research, and wellness sectors. Most of our work is driven by clinical demand in the NHS for digital services to modernise and revolutionise healthcare management in clinics and also the healthcare provision to patients in
- [Oliwia bio popup](https://www.elaros.com/?ae_global_templates=oliwia-bio-popup) - Oliwia ZwaraBusiness Communications Manager Oliwia was selected to join the company’s summer placement programme whilst completing her University of Sheffield’s MEng Bioengineering degree. Whilst specialising in Biomaterials and Tissue Engineering, the degree also offered her exposure to fields like computer science, medicine and material science as well as industry focused project management. Having worked on designing and
- [Nathan bio popup](https://www.elaros.com/?ae_global_templates=nathan-bio-popup) - Nathan Wells Summer Intern Nathan has recently completed the company’s summer placement program and has since been invited to work as an intern, after completing a Master’s degree in Bioengineering at the University of Sheffield.During Nathan’s final year at university, he specialised in the bacterial production of biodegradable plastics while also being exposed to other fields
- [Oscar bio popup](https://www.elaros.com/?ae_global_templates=oscar-bio-popup) - Oscar PetherickProgrammes Director Oscar joined ELAROS in July 2021, following the completion of the University of Sheffield’s multidisciplinary MEng Bioengineering degree. During his dissertation he evaluated in-silico methods for the assessment of non-invasive mask fit. Appointed to the role of Graduate Research and Development Associate, Oscar worked across all aspects of the development of the
- [Jennie bio popup](https://www.elaros.com/?ae_global_templates=jennie-bio-popup) - Prof. Jennie WilsonThe University of West London Jennie Wilson has a first degree in microbiology, a Master’s in Public Health, PhD in surveillance of healthcare associated infection (HCAI) and is a registered nurse. She has 30 years’ experience in infection prevention & control (IPC), has worked as a senior IPC practitioner in NHS Trusts in
- [James W bio popup](https://www.elaros.com/?ae_global_templates=james-w-bio-popup) - James WilliamsonUniversity of Hudderfield Dr James Williamson is a research fellow in the EPSRC Centre for Innovative Manufacturing in Advanced Metrology (CIMAM) at the University of Huddersfield.James has a BEng degree in Electronic Engineering awarded in 2010 from the University of Surrey. After two years in industry James joined CIMAM in 2012 for his PhD
- [Phil bio popup](https://www.elaros.com/?ae_global_templates=phil-bio-popup) - Phil WalkerPractical Information Governance Solutions Ltd Phil was the driving force behind NHS Information Governance for nearly two decades, leading the policy team at the Department of Health, introducing the Information Governance Toolkit to the service and developing much of the guidance that still shapes the way the care services work with data. For five
- [Jackie bio popup](https://www.elaros.com/?ae_global_templates=jackie-bio-popup) - Jackie SmithThe University of Manchester Jacky is a Professor of Respiratory Medicine at the University of Manchester and an Honorary Consultant at Manchester University NHS Foundation Trust. She runs a multi-disciplinary research team which focuses on understanding mechanisms underlying pathological cough and a regional clinical service seeing patients with refractory chronic cough. She is also
- [Alex bio popup](https://www.elaros.com/?ae_global_templates=alex-bio-popup) - Professor Alex HorsleyThe University of Manchester Alex is a Professor of Respiratory Medicine at the University of Manchester, consultant at the Manchester Adult Cystic Fibrosis (CF) Centre, and CF academic lead for the NIHR Manchester Biomedical Research Centre. He is a director of the NIHR Manchester Clinical Research Facility at Wythenshawe Hospital, where he oversees
- [Michelle bio popup](https://www.elaros.com/?ae_global_templates=michelle-bio-popup) - Michelle KudhailInspire Neurocare and Hamberley Care Homes Michelle is a neurophysiotherapist with a specialism in acquired brain injury, spinal cord injury and other neurological conditions for over 30 years. She has a broad experience having worked in the USA and the NHS and Independent sector in the UK.She has worked clinically in the field of
- [Helen bio popup](https://www.elaros.com/?ae_global_templates=helen-bio-popup) - Professor Helen DawesUniversity of Exeter Helen Dawes is Professor of Clinical Rehabilitation in the College of Medicine and Health. She is themelead for rehabilitation in the NIHR Exeter BRC and co-director of health technologies at Exeter network and business engagement and innovation.Helen is a clinical academic physiotherapist working in multidisciplinary research across ages, conditions, and
- [Nikki bio popup](https://www.elaros.com/?ae_global_templates=nikki-bio-popup) - Dr Nikki CordellCordell Health Nikki is an accredited specialist in Occupational Medicine, and a Fellow of the Faculty of Occupational Medicine (FFOM), with over 15 years experience in delivering occupational health services, first within the military and subsequently in the private and third sector. She has a keen interest in medical education and having gained
- [Samit bio popup](https://www.elaros.com/?ae_global_templates=samit-bio-popup) - Dr Samit ChakrabartyUniversity of Leeds Dr Samit Chakrabarty has studied the role of spinal circuits in the execution of motor tasks and their modulation by peripheral sensory and descending inputs from the brain, focusing on the plastic changes that the system undergoes during development or disease. After a PhD in Neurophysiology from the University of
- [Ruaridh bio popup](https://www.elaros.com/?ae_global_templates=ruaridh-bio-popup) - Prof. Ruairidh MilneLong COVID PPI Lead Ruairidh Milne has had Long Covid since March 2020. He is Co-Lead for Patient and Public Involvement for the NIHR-funded Locomotion study. He is a retired public health doctor and academic, whose most recent work was with the National Institute for Health and Care Research. Ruairidh met ELAROS throught
- [Grad R&D Associate](https://www.elaros.com/?ae_global_templates=grad-rd-associate) - Graduate Research and Development Associate Principal duties and responsibilitiesSupporting Elaros’ immediate growth strategy to access regional, national, and international marketsDriving forwards Elaros’ commercialisation of its C19-YRS Long Covid platform, both nationally and internationally, which will include:Product testing, refinement, and developmentSystem demonstrations, staff training and technical supportEngaging with clinical care and other NHS organisations to increase
- [P&P Bio Pop-Up](https://www.elaros.com/?ae_global_templates=pp-bio-pop-up) - Pipe&PiperSoftware Development Partners Pipe&Piper Ltd is ELAROS’ long-term strategic technology development partners who we have worked with for a number of years to help bring ELAROS’ ideas into reality.It is through ELAROS’ first product, the Digital Bladder Diary, which P&P helped to rapidly develop the C19-YRS system into world-leading, award-winning, long Covid assessment and management
- [Henry bio popup](https://www.elaros.com/?ae_global_templates=henry-bio-popup) - Henry RobinsonRegulatory Affairs & IT Manager In July 2022, Henry began in the new role of Regulatory Affairs and IT Manager. In this role he will ensure that Elaros and its products conform to the highest regulatory standards, and that our IT systems are secure for both staff and customers. He will bring his experiences

## Categories

- [Academia](https://www.elaros.com/category/uncategorized/)
- [Training](https://www.elaros.com/category/training/)
- [Staff Announcement](https://www.elaros.com/category/staff-announcement/)
- [Research](https://www.elaros.com/category/research/)
- [Conferences and Presentations](https://www.elaros.com/category/conferences-and-presentations/)
- [C19-YRS](https://www.elaros.com/category/c19-yrs/)
- [Awards and Competitions](https://www.elaros.com/category/awards/)
- [Partnerships](https://www.elaros.com/category/partnerships/)
- [Projects](https://www.elaros.com/category/projects/)
- [Mi-Trial](https://www.elaros.com/category/projects/mi-trial/)